Mobivity (MFON) 10-K 30 Mar 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Mar. 15, 2020	Jun. 30, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	MOBIVITY HOLDINGS CORP.
Entity Central Index Key	0001447380
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,615,469
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019
Entity Public Float			$ 30,741,668
Entity File Number	000-53851
Tax Identification Number (TIN)	26-3439095
Entity Incorporation, State Country Code	NV
Entity Interactive Data Current	Yes
Entity Address, Address Line One	55 North Arizona Place
Entity Address, Address Line Two	#310 Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85225
City Area Code	877
Local Phone Number	282-7660

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash	$ 273,599	$ 554,255
Accounts receivable, net of allowance for doubtful accounts of $88,071 and $10,104, respectively	614,726	601,658
Contracts receivable, current	526,948	578,869
Other current assets	601,749	736,309
Total current assets	2,017,022	2,471,091
Goodwill	496,352	537,550
Right to use lease assets	260,645	0
Intangible assets, net	1,762,211	1,781,448
Contracts receivable, long term	1,260,371	2,113,823
Other assets	67,787	527,146
TOTAL ASSETS	5,864,388	7,431,058
Current liabilities
Accounts payable	3,256,888	1,731,628
Accrued interest	35,292	9,167
Accrued and deferred personnel compensation	244,953	350,311
Deferred revenue and customer deposits	440,309	1,956,938
Related party notes payable, net - current maturities	140,700	131,392
Notes payable, net - current maturities	540,576	1,148,198
Other current liabilities	566,808	723,636
Total current liabilities	5,225,526	6,051,270
Non-current liabilities
Related party notes payable, net - long term	1,000,000	0
Notes payable, net - long term	567,529	194,328
Other long term liabilities	785,678	860,500
Total non-current liabilities	2,353,207	1,054,828
Total liabilities	7,578,733	7,106,098
Commitments and Contingencies (See Note 9)	0	0
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized; 51,380,969 and 45,998,053, shares issued and outstanding	51,381	45,998
Equity payable	100,862	100,862
Additional paid-in capital	94,781,738	88,008,473
Accumulated other comprehensive loss	8,780	4,759
Accumulated deficit	(96,657,106)	(87,835,132)
Total stockholders' equity	(1,714,345)	324,960
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 5,864,388	$ 7,431,058

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 88,071	$ 10,104	$ 2,280
Common stock, par value	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	51,380,969	45,998,053	37,025,140
Common stock, shares outstanding	51,380,969	45,998,053	37,025,140

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues
Revenues	$ 10,056,922	$ 11,556,536
Cost of revenues	5,938,298	3,932,334
Gross profit	4,118,624	7,624,202
Operating expenses
General and administrative	5,588,329	4,155,636
Sales and marketing	2,707,356	3,931,469
Engineering, research, and development	3,609,968	3,713,787
Depreciation and amortization	600,066	486,255
Total operating expenses	12,505,719	12,287,147
Income (loss) from operations	(8,387,095)	(4,662,945)
Other income/(expense)
Interest income	28,160	4,145
Interest expense	(236,706)	(210,422)
Goodwill impairment	0	(2,288,057)
Loss on sale of fixed assets	0	(8,722)
Loss on conversion of debt	(232,462)	(41,903)
Foreign currency gain (loss)	6,129	(7,745)
Total other income/(expense)	(434,879)	(2,552,704)
Income (loss) before income taxes	(8,821,974)	(7,215,649)
Income tax expense	0	0
Net Income (loss)	(8,821,974)	(7,215,649)
Other comprehensive income (loss), net of income tax
Foreign currency translation adjustments	4,021	70,523
Comprehensive income (loss)	$ (8,817,953)	$ (7,145,126)
Net income (loss) per share:
Basic and Diluted	$ (0.18)	$ (0.17)
Weighted average number of shares:
Basic and Diluted	47,720,507	42,133,368

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Accumulated Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2017	$ 37,025	$ 100,862	$ 77,910,842	$ (65,764)	$ (80,619,483)	$ (2,636,518)
Beginning balance, Shares at Dec. 31, 2017	37,025,140
Issuance of common stock for cash	$ 5,775		5,769,225			5,775,000
Issuance of common stock for cash, Shares	5,775,000
Issuance of common stock for warrant conversion	$ 2,103		2,253,358			2,255,461
"Issuance of common stock for warrant conversion, Shares	2,102,804
Issuance of common stock for debt conversion	$ 1,048		1,088,439			1,089,487
Issuance of common stock for debt conversion, Shares	1,047,583
Issuance of common stock for cashless warrant conversion	$ 10		(10)
Issuance of common stock for cashless warrant conversion, Shares	10,234
Issuance of common stock for options exercised	$ 37		21,458			21,495
Issuance of common stock for options exercised, Shares	37,292
Stock based compensation			965,161			965,161
Foreign currency translation adjustment				70,523		70,523
Net income (loss)					(7,215,649)	(7,215,649)
Ending balance, value at Dec. 31, 2018	$ 45,998	100,862	88,008,473	4,759	(87,835,132)	324,960
Ending balance, shares at Dec. 31, 2018	45,998,053
Issuance of common stock for cash	$ 2,800		2,797,200
Issuance of common stock for cash, Shares	2,800,000
Issuance of common stock for debt conversion	$ 2,583		2,812,795
Issuance of common stock for debt conversion, Shares	2,582,916
Stock based compensation			1,163,270
Foreign currency translation adjustment				4,021		4,021
Net income (loss)					(8,821,974)	(8,821,974)
Ending balance, value at Dec. 31, 2019	$ 51,381	$ 100,862	$ 94,781,738	$ 8,780	$ (96,657,106)	$ (1,714,345)
Ending balance, shares at Dec. 31, 2019	51,380,969

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
OPERATING ACTIVITIES
Net loss	$ (8,821,974)	$ (7,215,649)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	103,284	33,477
Loss on conversion of debt	232,462	41,903
Amortization of deferred financing costs	0	0
Stock-based compensation	1,163,270	965,161
Loss on disposal of fixed assets	0	8,722
Depreciation and amortization expense	600,066	425,247
Goodwill impairment	0	2,288,057
Adjustments due to ASC 606	464,510	(1,209,823)
Increase (decrease) in cash resulting from changes in:
Accounts receivable	(115,288)	249,479
Other current assets	569,430	(946,448)
Operating lease assets/liabilities	14,887	0
Other assets	8,615	0
Accounts payable	1,581,238	582,700
Accrued interest	109,041	120,304
Accrued and deferred personnel compensation	(96,790)	(244,874)
Other liabilities - non-current	(31,028)	(157,630)
Other liabilities - current	(5,178)	(17,550)
Deferred revenue and customer deposits	(1,516,832)	528,012
Net cash used in operating activities	(5,740,287)	(4,548,912)
INVESTING ACTIVITIES
Purchases of equipment	(12,277)	(20,306)
Acquisition of Belly	0	(3,000,000)
Cash paid for patent	(5,025)	0
Capitalized software development costs	(539,931)	(504,845)
Net cash used in investing activities	(557,233)	(3,525,151)
FINANCING ACTIVITIES
Payments on notes payable	(305,345)	(3,049,222)
Proceeds from related party notes payable	3,500,000	0
Proceeds from notes payable	0	3,095,000
Proceeds from issuance of common stock, net of issuance costs	2,800,000	8,051,958
Net cash provided by financing activities	5,994,655	8,097,736
Effect of foreign currency translation on cash flow	22,209	70,523
Net change in cash	(280,656)	94,196
Cash at beginning of period	554,255	460,059
Cash at end of period	273,599	554,255
Cash paid during period for:
Interest	210,581	210,422
Non-cash investing and financing activities:
Issuance of common stock for cashless exercise	0	10
Issuance of common stock for debt conversion	2,582,916	1,047,584
Lease adoption	$ 538,740	$ 0

1. The Company and Summary of S

1. The Company and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
1. The Company and Summary of Significant Accounting Policies	1. The Company and Summary of Significant Accounting Policies The Company Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns. Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence. Measure, predict, and boost guest frequency and spend by channel. Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program. Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs. Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Baskin Robbins, Chick-fil-A and Checkers/Rally’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 — - The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands. Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees. Liquidity We have $273,599 of cash as of December 31, 2019. We had a net loss of $8.8 million for the year then ended, and we used $5.7 million of cash in our operating activities during 2019. Since December 31, 2019 and through the date of this report, we issued an unsecured note in the amount of $200,000, which is due February 2022. On March 2, 2020 we received proceeds of $234,500 in conjunction with a shareholder exercising stock warrants. This exercise was at a strike price of $1.00 in exchange for 234,500 shares of common stock. This unsecured note alleviated the doubt of a going concern for the Company. Based on our projected 2020 results and, if necessary, our ability to reduce certain variable operating expenses, we believe that our existing capital, and operations, will be sufficient to finance our operations through the first quarter of 2021. If our cash reserves prove insufficient to sustain operations, we plan to raise additional capital by selling shares of capital stock or other equity or debt securities. However, there are no commitments or arrangements for future financings in place at this time, and we can give no assurance that such capital will be available on favorable terms or at all. We may need additional financing thereafter until we can achieve profitability. If we cannot, we will be forced to curtail our operations or possibly be forced to evaluate a sale or liquidation of our assets. Any future financing may involve substantial dilution to existing investors. Although we are actively pursuing financing opportunities, we may not be able to raise cash on terms acceptable to us or at all. There can be no assurance that we will be successful in obtaining additional funding. Financings, if available, may be on terms that are dilutive to our shareholders, and the prices at which new investors would be willing to purchase our securities may be lower than the current price of our ordinary shares. The holders of new securities may also receive rights, preferences or privileges that are senior to those of existing holders of our ordinary shares. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations in the short term. Principles of Consolidation and Basis of Presentation The accompanying financial statements are consolidated and include the financial statements of Mobivity Holdings Corp. and our wholly-owned subsidiary. Intercompany transactions are eliminated. Use of Estimates Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management's best knowledge of current events and actions we may undertake in the future. Significant estimates used are those related to: stock-based compensation; valuation of acquired assets, intangible assets and liabilities; useful lives for depreciation and amortization of long-lived assets; future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets; valuation of derivative liabilities; valuation allowance for deferred tax assets; and contingencies. Actual results may ultimately differ from estimates, although management does not generally believe such differences would materially affect the consolidated financial statements in any individual year. However, in regard to ongoing impairment testing of goodwill and indefinite-lived intangible assets, significant deterioration in future cash flow projections or other assumptions used in estimating fair values versus those anticipated at the time of the initial valuations, could result in impairment charges that materially affect the consolidated financial statements in a given year. Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss. Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts. Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2019, and 2018, we recorded an allowance for doubtful accounts of $88,071 and $10,104, respectively. From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred. As of December 31, 2019, we had two customer whose balance represented 53% of total accounts receivable. As of December 31, 2018, we had one customer whose balance represented 34% of total accounts receivable. Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2019 and 2018. As a result of these tests, we recorded impairment charges to our goodwill of $0 and $2,288,057 for the years ended December 31, 2019 and 2018, respectively. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. The Company’s evaluation of its long-lived assets completed during the years ended December 31, 2019 and 2018 resulted in no impairment charges. Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset completed during the years ended December 31, 2019 and 2018 resulted in no impairment charges. Derivative Financial Instruments We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Going Concern Assumption These financial statements are prepared on a going concern basis. This requires management to evaluate whether it is probable that known conditions or events, considered in the aggregate, would raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. If such conditions or events are identified, the standard requires management’s mitigation plans to alleviate the doubt or a statement of the substantial doubt about the entity’s ability to continue as a going concern to be disclosed in the financial statements. During management’s evaluation, substantial doubt was raised about the entity’s ability to continue as a going concern. As a result of this evaluation, the Company has undertaken financing efforts (as further described in Note 16) to provide continuing financial support so that the Company is able to pay its debts as and when they fall due. Management has concluded that the doubt raised has been alleviated by the additional financing. Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month to month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”) is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. During the years ended December 31, 2019 and 2018, two customers accounted for 70% and 67% of our revenues, respectively. Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements and other direct costs. Advertising expense was $40,993 and $88,569 for years ended December 31, 2019 and 2018, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $139,392 and $127,827 of expense related to those activities for the years ended December 31, 2019 and 2018, respectively. Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained. Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2019 and 2018 which were excluded from the calculation because their effect was anti-dilutive. December 31, 2019 2018 Outstanding employee options 5,781,884 5,012,218 Outstanding restricted stock units 1,152,248 662,800 Outstanding warrants 3,358,459 2,087,060 10,292,591 7,762,078 Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In May 2014, the FASB issued ASU 2014-09 regarding ASC Topic 606, “Revenue from Contracts with Customers.” ASU 2014-09 provides principles for recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14 to defer the effective date by one year with early adoption permitted as of the original effective date. This guidance was effective for the Company for its fiscal year beginning January 1, 2018. The Company adopted the modified retrospective approach to initially apply the update and recognize the remaining contract value at the date of application. In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)”. Under this guidance, an entity is required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. This guidance offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. The Company adopted this standard as of January 1, 2019. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230).” ASU No. 2016-18 requires that restricted cash be included with cash and cash equivalents when reconciling the change in cash flow. This guidance is reflected in these financial statements.

2. Acquisitions

2. Acquisitions	12 Months Ended
	Dec. 31, 2019
Business Combinations [Abstract]
2. Acquisitions	2. Acquisitions We completed the following acquisition in furtherance of our strategy to acquire small, privately owned enterprises in the mobile marketing sector through asset purchase structures. We made the acquisitions to expand our market presence and product offerings. The purchase consideration for each acquisition was allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date, with the remaining unallocated consideration recorded as goodwill. An independent valuation expert assisted us in determining these fair values. We have included the financial results of these acquisitions in our consolidated financial statements from the date of acquisition. Acquisition On November 14, 2018, we entered into an Asset Purchase Agreement with Belly, Inc., a Delaware corporation, pursuant to which we have agreed to purchase from Belly, and Belly has agreed to sell to us, certain operating assets relating to Belly’s proprietary digital customer loyalty platform, including client contracts, accounts receivable and intellectual property, in exchange for our payment of $3,000,000, subject to working capital adjustments. Belly was founded in 2001 and was originally funded by Andreessen Horowitz, Lightbank, NEA, DAG Ventures, Cisco and 7-Ventures, LLC (a subsidiary of 7-Eleven, Inc). Belly is a platform-first technology company enabling businesses of all sizes to create digital connections that result in personal relationships with their customers. Belly’s platform has been deployed to more than 5,000 merchant locations and 7 million consumers. Our acquisition of the Belly assets is expected to be accretive to our top and bottom line revenue figures. The Asset Purchase Agreement contains customary representations, warranties and indemnities on the part of Belly. The closing of the acquisition is expected to take place on or about November 14, 2018, subject to usual and customary closing conditions. We intended to finance the acquisition through our cash on hand. In connection with our acquisition of the Belly assets, on November 14, 2018, we entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement provides for a single-term loan to us in the original principal amount of $1,000,000. Interest accrues on the unpaid principal amount at the rate of prime plus 1.5%. The loan is a three-year loan and is interest-only payable for the first six months of the loan. Commencing on May 1, 2019, we will commence monthly payments of principal in the amount of $33,333 in addition to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. The acquisition was accounted for as an acquisition of asset and we valued all assets and liabilities acquired at their fair values on the date of acquisition. An independent valuation expert assisted us in determining these fair values. The assets and liabilities of the acquired entity were recorded at their estimated fair values at the date of the acquisition. The allocation of the purchase price to assets and liabilities based upon fair value determinations was as follows: Estimated Tangible and Intangible Net Assets Accounts receivable, net $ 9,400 Property and equipment 21,522 Other current assets & Prepaid expenses 18,009 IP/Technology/Patents 991,300 Goodwill 2,022,489 Total identifiable assets acquired 3,062,720 Liabilities assumed (62,720) Net assets acquired $ 3,000,000 The purchase price consisted of $3,000,000 of cash on hand. The following information presents unaudited pro forma consolidated results of operations for the years ended December 31, 2018, as if the Belly asset acquisition described above had occurred on January 1, 2017. The pro forma financial information is not necessarily indicative of the operating results that would have occurred if the acquisition been consummated as of the date indicated, nor are they necessarily indicative of future operating results. Mobivity Holdings Corp. Unaudited Pro Forma Condensed Combined Statement of Operations For the Year Ended December 31, 2018 Pro Forma Mobivity Belly Combined Revenues Revenues $ 11,556,536 $ 2,374,846 $ 13,931,382 Cost of revenues 3,932,334 658,999 4,591,333 Gross profit 7,624,202 1,715,847 9,340,049 Operating expenses General and administrative 4,197,539 542,136 4,739,675 Sales and marketing 3,931,469 71,543 4,003,012 Engineering, research, and development 3,713,787 64,699 3,778,486 Goodwill impairment 2,288,057 - 2,288,057 Depreciation and amortization 486,255 18,926 505,181 Total operating expenses 14,617,107 697,304 15,314,411 Income (loss) from operations (6,992,905) 1,018,543 (5,974,362) Other income/(expense) Interest income 4,145 - 4,145 Interest expense (210,422) - (210,422) Gain on sale of fixed assets (8,722) - (8,722) Other income - 20,678 20,678 Foreign currency (loss) gain (7,745) - (7,745) Total other income/(expense) (222,744) 20,678 (202,066) Income (loss) before income taxes (7,215,649) 1,039,221 (6,176,428) Income tax expense - - - Net Income (loss) (7,215,649) 1,039,221 (6,176,428) Other comprehensive income (loss), net of income tax Foreign currency translation adjustments 70,523 - 70,523 Comprehensive income (loss) $ (7,145,126) $ 1,039,221 $ (6,105,905) Net loss per share: Basic and diluted $ (0.17) $ (0.15) Weighted average number of shares: Basic and diluted 42,133,368 42,133,368

3. New Accounting Standards

3. New Accounting Standards	12 Months Ended
	Dec. 31, 2019
Accounting Changes and Error Corrections [Abstract]
3. New Accounting Standards	3. New Accounting Standards Revenue from Contracts with Customers. In May 2014, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, Revenue from Contracts with Customers (“ASC 606”) Our transition to ASC 606 represents a change in accounting principle. ASC 606 eliminates industry-specific guidance and provides a single revenue recognition model for recognizing revenue from contracts with customers. The core principle of ASC 606 is that a reporting entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the reporting entity expects to be entitled for the exchange of those goods or services. The Company adopted the new standard in the first quarter of its fiscal 2018, using the modified retrospective method. The Company implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The most significant impact of the adoption of ASC 606 to the Company relates to the acceleration of revenue recognition for sale of custom products subject to non-cancellable customer purchase orders. The new standard will primarily impact the Company’s revenue recognition for software arrangements. In this area, the new standard will accelerate the recognition of revenue. The table below details both the current and expected revenue recognition timing in these areas: Software arrangements: Past revenue standard New ASC 606 revenue standard Perpetual software licenses Upfront Upfront Enterprise license agreements Ratable Upfront Software support Ratable Ratable SaaS Ratable Ratable The adoption of ASC 606 has an impact on the Company’s Consolidated Statements of Operations and Consolidated Balance Sheets but has no impact on cash provided by or used in operating, financing, or investing activities on the Consolidated Statements of Cash Flows. Financial Statement Impact of Transition to ASC 606 As noted above, we transitioned to ASC 606 using the modified retrospective method on January 1, 2018. The cumulative effect of this transition to applicable contracts with customers that were not completed as of January 1, 2018 was recorded as an adjustment to stockholders’ equity as of that date. As a result of applying the modified retrospective method to transition to ASC 606, the following adjustments were made to the consolidated balance sheet as of January 1, 2018: December 31, Adjusted 2017 Adjustments January 1, As Reported due to ASC 606 2018 ASSETS Current assets Cash $ 460,059 $ - $ 460,059 Accounts receivable, net of allowance for doubtful accounts of $2,280 885,743 544,599 1,430,342 Other current assets 209,536 - 209,536 Total current assets 1,555,338 544,599 2,099,937 Goodwill 803,118 - 803,118 Intangible assets, net 676,436 - 676,436 Accounts receivable, long term - 424,023 424,023 Other assets 88,916 - 88,916 TOTAL ASSETS $ 3,123,808 $ 968,622 $ 4,092,430 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 1,096,003 $ - $ 1,096,003 Accrued interest 1,168 - 1,168 Accrued and deferred personnel compensation 590,500 - 590,500 Deferred revenue and customer deposits 1,429,266 - 1,429,266 Notes payable, net - current maturities 2,236,224 - 2,236,224 Other current liabilities 226,355 191,121 417,476 Total current liabilities 5,579,516 191,121 5,770,637 Non-current liabilities Notes payable, net - long term 180,810 - 180,810 Other long term liabilities - 150,477 150,477 Total non-current liabilities 180,810 150,477 331,287 Total liabilities 5,760,326 341,598 6,101,924 Commitments and Contingencies (See Note 9) Stockholders' equity Common stock, $0.001 par value; 100,000,000 shares authorized; 37,025,140 and 37,025,140, shares issued and outstanding 37,025 - 37,025 Equity payable 100,862 - 100,862 Additional paid-in capital 77,910,842 - 77,910,842 Accumulated other comprehensive loss (65,764) - (65,764) Accumulated deficit (80,619,483) 627,024 (79,992,459) Total stockholders' equity (2,636,518) 627,024 (2,009,494) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,123,808 $ 968,622 $ 4,092,430 The following tables reflect the impact of adoption of ASC 606 on our condensed consolidated statements of operations for the year ended December 31, 2018 and our condensed consolidated balance sheet as of December 31, 2018 and the amounts as if the Previous Standards were in effect (“Amounts Under Previous Standards”): Condensed Consolidated Statement of Operations Twelve Months Ended December 31, 2018 As reported Total Adjustments Under ASC 606 Amounts Under Previous Standards Revenues Revenues $ 11,556,536 $ 2,692,692 $ 8,863,844 Cost of revenues 3,932,334 - 3,932,334 Gross profit 7,624,202 2,692,692 4,931,510 Operating expenses General and administrative 4,155,636 148,287 4,007,349 Sales and marketing 3,931,469 - 3,931,469 Engineering, research, and development 3,713,787 1,334,582 2,379,205 Depreciation and amortization 486,255 - 486,255 Total operating expenses 12,287,147 1,482,869 10,804,278 Income (loss) from operations (4,662,944) 1,209,823 (5,872,768) Other income/(expense) Interest income 4,145 - 4,145 Interest expense (210,422) - (210,422) Goodwill impairment (2,288,057) - (2,288,057) Loss on sale of fixed assets (8,722) (8,722) Loss on conversion of debt (41,903) (41,903) Foreign currency loss (7,745) - (7,745) Total other income/(expense) (2,552,704) - (2,552,704) Income (loss) before income taxes (7,215,649) 1,209,823 (8,425,472) Income tax expense - - - Net income (loss) (7,215,649) 1,209,823 (8,425,472) Other comprehensive income (loss), net of income tax Foreign currency translation adjustments 70,523 - 70,523 Comprehensive income (loss) $ (7,145,126) $ 1,209,823 $ (8,354,949) Net income (loss) per share: Basic $ (0.17) $ 0.03 $ (0.20) Weighted average number of shares outstanding: Basic 42,133,368 42,133,368 42,133,368 Condensed Consolidated Balance Sheet December 31, 2018 As Reported Total Adjustments Under ASC 606 Amounts Under Previous Standards ASSETS Current assets Cash $ 554,255 $ - $ 554,255 Accounts receivable, net of allowance for doubtful accounts of $9,828 601,658 - 601,658 Contracts receivable, current 578,869 (578,869) - Other current assets 736,309 - 736,309 Total current assets 2,471,091 (578,869) 1,892,222 Goodwill 537,550 - 537,550 Intangible assets, net 1,781,448 - 1,781,448 Contracts receivable, long term 2,113,823 (2,113,823) - Other assets 527,146 - 527,146 TOTAL ASSETS $ 7,431,058 $ (2,692,692) $ 4,738,366 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 1,731,628 $ - $ 1,731,628 Accrued interest 9,167 - 9,167 Accrued and deferred personnel compensation 350,311 - 350,311 Deferred revenue and customer deposits 1,956,938 - 1,956,938 Notes payable, net - current maturities 1,279,590 - 1,279,590 Other current liabilities 723,636 (622,369) 101,267 Total current liabilities 6,051,270 (622,369) 5,428,901 Non-current liabilities Notes payable, net - long term 194,328 - 194,328 Other long term liabilities 860,500 (860,500) Total non-current liabilities 1,054,828 (860,500) 194,328 Total liabilities 7,106,098 (1,482,869) 5,623,229 Commitments and Contingencies (See Note 9) Stockholders' equity Common stock, $0.001 par value; 100,000,000 shares authorized; 45,998,053 and 45,998,053, shares issued and outstanding 45,998 - 45,998 Equity payable 100,862 - 100,862 Additional paid-in capital 88,008,473 - 88,008,473 Accumulated other comprehensive loss 4,759 - 4,759 Accumulated deficit (87,835,132) (1,209,823) (89,044,955) Total stockholders' equity 324,960 (1,209,823) (884,863) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 7,431,058 $ (2,692,692) $ 4,738,366

4. Goodwill and Intangible Asse

4. Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
4. Goodwill and Intangible Assets	4. Goodwill and Intangible Assets Goodwill The following table presents goodwill and impairment for the years ended December 31, 2019 and 2018: Goodwill December 31, 2017 $ 803,118 Acquired 2,022,489 Impairment (2,288,057) December 31, 2018 537,550 Acquired (41,198) Impairment - December 31, 2019 $ 496,352 We conducted our annual impairment test of goodwill as of December 31, 2019 and 2018, which resulted in impairment charges of $0 and $2,288,057, respectively. Intangible assets The following table presents components of identifiable intangible assets for the years ended December 31, 2019 and 2018: December 31, 2019 December 31, 2018 Gross Accumulated Net Carrying Weighted Gross Accumulated Net Carrying Weighted Patents and trademarks $ 183,583 $ (113,730) $ 69,853 14 $ 177,944 $ (72,957) $ 104,987 15 Customer and merchant 2,321,112 (1,581,876) 739,236 10 2,343,112 (1,507,024) 836,088 10 Trade name 197,924 (147,192) 50,732 10 197,868 (137,872) 59,996 10 Acquired technology 684,540 (539,748) 144,792 10 684,540 (523,448) 161,092 10 Non-compete agreement 79,299 (18,368) 60,931 2 79,299 (2,508) 76,791 2 $ 3,466,458 $ (2,400,914) $ 1,065,544 $ 3,482,763 $ (2,243,809) $ 1,238,954 During the years ended December 31, 2019 and 2018, we recorded amortization expense related to our intangible assets of $178,653 and $63,795, respectively, which is included in depreciation and amortization in the consolidated statement of operations. During the years ended December 31, 2019 and 2018, we recorded no impairment charges related to our intangible assets. Expected future intangible asset amortization as of December 31, 2019 is as follows: Year ending December 31, Amount 2020 $ 150,737 2021 148,045 2022 147,868 2023 145,359 2024 108,764 Thereafter 364,771 Total $ 1,065,544

5. Software Development Costs

5. Software Development Costs	12 Months Ended
	Dec. 31, 2019
Research and Development [Abstract]
5. Software Development Costs	5. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The following table presents details of our software development costs for the years ended December 31, 2019 and 2018: December 31, 2019 December 31, 2018 Gross Accumulated Net Carrying Weighted Gross Accumulated Net Carrying Weighted $ 2,245,811 $ (1,549,144) $ 696,667 2 $ 1,781,902 $ (1,239,408) $ 542,494 2 $ 2,245,811 $ (1,549,144) $ 696,667 $ 1,781,902 $ (1,239,408) $ 542,494 Software development costs are being amortized on a straight-line basis over their estimated useful life of two years. During the years ended December 31, 2019 and 2018, we recorded amortization expense for software development costs of $309,736 and $326,631, respectively which is included in depreciation and amortization in the consolidated statement of operations. During the years ended December 31, 2019 and 2018, we recorded no impairment charges related to our software development costs. The estimated future amortization expense of software development costs as of December 31, 2019 is as follows: Year ending December 31, Amount 2019 $ 479,188 2020 217,092 2021 398 2022 - 2023 - Thereafter - Total $ 696,667

6. Operating Lease Assets

6. Operating Lease Assets	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
6. Operating Lease Assets	6. Operating Lease Assets Adoption of Accounting Standards Codification (“ASC”) Topic 842, “Leases." The following are additional details related to leases recorded on our balance sheet as of December 31, 2019: Leases Classification Amount Assets Operating lease assets Operating lease assets $ 260,645 Total lease assets $ 260,645 Liabilities Current Operating lease liabilities Operating lease liabilities $ 258,343 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 45,460 Total lease liabilities $ 303,803 During the year ended December 31, 2019, we recorded amortization expense of $4,419 related to the accretion of the lease liability, which is included in depreciation and amortization in the consolidated statement of operations. Rent expense was $320,496 and $416,080 for the years ended December 31, 2019 and 2018, respectively. The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2020 $ 270,982 2021 35,748 2022 11,916 2023 - 2024 - Thereafter - Total future lease payments 318,646 Less: imputed interest (14,843) Total $ 303,803 Weighted Average Remaining Lease Term (years) Operating leases 1.34 Weighted Average Discount Rate 6.75%

7. Notes Payable and Interest E

7. Notes Payable and Interest Expense	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
7. Notes Payable and Interest Expense	7. Notes Payable and Interest Expense Notes Payable The following table presents details of our notes payable as of December 31, 2019 and 2018: Facility Maturity Interest Rate Balance at Balance at BDC Term Loan October 15, 2021 25 % $ 224,307 $ 252,837 ACOA Note May 1, 2021 - 117,131 141,081 Wintrust Bank November 1, 2021 Prime + 1.5 % 766,667 1,000,000 Related Party Note March 31, 2020 15 % 1,140,700 80,000 Total Debt 2,248,805 1,473,918 Less current portion (681,276) (1,279,590) Long-term debt, net of current portion $ 1,567,529 $ 194,328 Principal payments on notes payables are due as follows: Year ending December 31, Amount 2020 $ 681,276 2021 1,521,070 2022 37,971 2023 8,488 2024 - Thereafter - Total future debt payments 2,248,805 BDC Term Loan On January 8, 2016, Livelenz (a wholly-owned subsidiary of the Company,) entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on December 15, 2018. The company recorded $1,529 of debt issuance costs as part of the acquisition of Livelenz. During the twelve months ended December 31, 2018, the company recorded $856 of amortization expense. As of December 31, 2018, the company has $0 of debt issuance costs remaining. On January 8, 2018, Livelenz (a wholly-owned subsidiary of the Company,) entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on September 15, 2019. Under this amendment the interest rate on the loan increases to 20%. On July 26, 2019, Livelenz, entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on October 15, 2021. In accordance with the amendment, the Company will commence monthly payments beginning on August 15, 2019 of principal in the amount of $8,500 in addition to the monthly payment of accrued interest. These payments increase to $10,000 on November 15, 2019, $12,000 on May 15, 2020, $14,000 on November 15, 2020 and $16,000 on May 15, 2021 in addition to the monthly interest. ACOA Note On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature, repayments began on June 1, 2016, and the commitments will terminate on May 1, 2023. The monthly principal payment amount of $3,000 increased to $3,500 beginning on November 1, 2019, $4,000 on November 1, 2020, $4,500 on November 1, 2021 and $2,215 during the remaining term of the agreement. SVB Working Capital Line of Credit Facility In March 2016, we entered into a Working Capital Line of Credit Facility (the “Facility”) with Silicon Valley Bank (“SVB”) to provide up to $2 million to finance our general working capital needs. The Facility is funded based on cash on deposit balances and advances against our accounts receivable based on customer invoicing. Interest on Facility borrowings is calculated at rates between the prime rate minus 1.75% and prime rate plus 3.75% based on the borrowing base formula used at the time of borrowing. The Facility contains standard events of default, including payment defaults, breaches of representations, breaches of affirmative or negative covenants, and bankruptcy. As of March 31, 2018, this Facility was paid off and closed. Under the terms of the Facility, the Company is obligated to pay a commitment fee on the available unused amount of the Facility commitments equal to 0.5% per annum. The Company capitalized debt issuance costs of $47,287 as of December 31, 2017 related to the Facility, which are being amortized on a straight-line basis to interest expense over the two-year term of the Facility. During the twelve months ended December 31, 2018, the company recorded $27,393 of amortization expense. As of December 31, 2018, the company has $0 of debt issuance costs remaining. Bridge Loan Promissory Note On April 19, 2018, the Company entered into a bridge financing agreement (“Promissory Note”) for up to $1,000,000. The Promissory Note carries an interest rate of 2% per thirty days and a facility fee of 1% of the maximum loan amount. Under this agreement the note automatically renews every thirty days until paid in full. As of September 30, 2018, this Promissory Note has been paid off and closed. Wintrust Loan On November 14, 2018, we entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement provides for a single-term loan to us in the original principal amount of $1,000,000. Interest accrues on the unpaid principal amount at the rate of prime plus 1.5%. The loan is a three-year loan and is interest-only payable for the first six months of the loan. Commencing on May 1, 2019, we will commence monthly payments of principal in the amount of $33,333 in addition to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. We used the proceeds of the loan to re-finance a loan in the principal amount of $1,000,000 we assumed as part of the acquisition of the Belly assets. As of December 31,2019, we did not comply with our covenants under this Loan. Related Party Notes During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than December 1, 2018. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. As of December 31, 2019, we have repaid $1,000,000 and have $80,000 as a remaining balance of these notes plus accrued interest for $21,333. During the year ended December 31, 2019 we issued unsecured notes in the principle aggregate amount of $3,500,000, which become due two years after the date of issuance. These notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. On July 2, 2019 $2,500,000 this note and the accrued interest of $82,916 was converted into equity and we recorded a loss on conversion of debt of $232,462 for the year ended December 31, 2019. As of December 31, 2019, we have a principal balance of $1,000,000 and accrued interest of $13,958 outstanding. Interest Expense The following table summarizes interest expense for the years ended December 31, 2019 and 2018: December 31, 2019 2018 Interest expense $ 236,706 $ 210,422 Total interest expense $ 236,706 $ 210,422

8. Common Stock and Equity Paya

8. Common Stock and Equity Payable	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
8. Common Stock and Equity Payable	8. Common Stock and Equity Payable Common Stock 2018 On February 7, 2018, the Company issued 12,500 shares of our common stock, at a price of $0.78 per share, for the gross proceeds of $9,595 in conjunction with one employee that exercised vested stock options. On February 23, 2018, the Company issued 1,808 shares of our common stock in a cashless transaction related to a 25,000 warrant exercise. During the three months ended March 31, 2018, the Company issued 2,018,125 shares of common stock for $2,018,125 related to the exercise of certain warrants. In June 2018, the Company commenced a private placement of its common shares at an offering price of $1.00 per share. As of September 30, 2018, the Company had sold 5,775,000 shares of its common stock for gross proceeds of $5,775,000. In addition, the Company issued 1,047,583 shares of its common stock associated with the cancellation of $1,000,000 of principal, $47,583 of accrued interest, and a loss on conversion of $41,902 under its February 2018 private placement Notes (See Note 5). On August 29, 2018, the Company issued 24,792 shares of our common stock, at a price of $0.48 per share, for the gross proceeds of $11,875 in conjunction with one employee that exercised vested stock options. On October 19, 2018, the Company issued 84,679 shares of our common stock, at a price of $1.20 per share, for the gross proceeds of $101,615 in conjunction with the exercise of warrants. On November 6, 2018, the Company issued 8,426 shares of our common stock in a cashless transaction related to a 25,000 warrant exercise. On December 31, 2018, the Company recorded stock-based compensation expense of $260,000 related to restricted stock units for members of our board of directors. 2019 In July 2019, the Company commenced a private placement of its common stock units, with each unit consisting of one share of our common stock and a warrant to purchase to one-half share of our common stock at an exercise price of $1.25 per share at an offering price of $1.00 per unit. As of December 31, 2019, the Company had sold 2,800,000 units of its common stock for gross proceeds of $2,800,000. In addition, the Company issued 2,582,916 units of its common stock associated with the conversion of $2,500,000 of principal, $82,916 of accrued interest, and a loss on conversion of $232,462 (See Note 7). As of December 31, 2019, and 2018 we had an equity payable balance of $100,862.

9. Stock-based Plans and Stock-

9. Stock-based Plans and Stock-based Compensation	12 Months Ended
	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
9. Stock-based Plans and Stock-based Compensation	9. Stock-based Plans and Stock-based Compensation Stock-based Plans We have the 2010 Incentive Stock Option Plan and the 2013 Incentive Stock Option Plan under which we have granted stock options to our directors, officers and employees. At December 31, 2019, 5,781,884 shares were authorized under the plans and 30,728,202 shares were available for future grant. We believe that such awards better align the interests of our directors, officers and employees with those of our shareholders. Option awards are generally granted with an exercise price that equals the fair market value of our stock at the date of grant. These option awards generally vest based on four years of continuous service and have 10-year contractual terms. The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2019 and 2018: Shares Weighted Weighted Aggregate Outstanding at December 31, 2017 6,818,948 $ 1.06 8.12 $ 209,690 Granted 855,000 $ 1.25 - $ - Exercised (37,292) 0.57 Forfeit/canceled (1,566,589) $ 0.74 - $ - Expired (1,082,641) $ 1.18 - $ - Outstanding at December 31, 2018 4,987,426 $ 1.16 7.12 $ 1,215,067 Granted 2,592,500 $ 1.01 - $ - Exercised - $ - - $ - Forfeit/canceled (923,389) $ 1.00 - $ - Expired (874,653) $ 0.93 - $ - Outstanding at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868 Expected to vest at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868 Exercisable at December 31, 2019 3,339,437 $ 1.29 5.76 $ 343,255 Unrecognized expense at December 31, 2019 $ 1,568,273 The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At December 31, 2019, options to purchase 1,969,208 shares of common stock were in-the-money. The weighted average grant-date fair value of options granted during the years 2019 and 2018 was $0.71 and $1.25, respectively. 2018 On January 1, 2018, the Company granted two employees a total of 10,000 options to purchase shares of the Company common stock at the closing price as of January 1, 2018 of $1.20 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until January 1, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 104.04% and an option fair value of $.97 was $9,729. On January 8, 2018, the Company granted one employee a total of 50,000 options to purchase shares of the Company common stock at the closing price as of January 8, 2018 of $1.20 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until January 8, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 104.06% and an option fair value of $.97 was $48,682. On January 29, 2018, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of January 29, 2018 of $1.03 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until January 29, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 103.49% and an option fair value of $.83 was $16,690. On February 7, 2018, the Company issued 12,500 shares of our common stock, at a price of $0.78 per share, for the gross proceeds of $9,595 in conjunction with one employee that exercised vested stock options. On February 15, 2018, the Company granted one employee a total of 100,000 options to purchase shares of the Company common stock at the closing price as of February 15, 2018 of $1.12 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until February 15, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 103.60% and an option fair value of $.91 was $90,904. On March 26, 2018, the Company granted one employee a total of 300,000 options to purchase shares of the Company common stock at the closing price as of March 26, 2018 of $1.10 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until March 26, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 101.94% and an option fair value of $.88 was $265,575. On April 16, 2018, the Company granted one employee a total of 50,000 options to purchase shares of the Company common stock at the closing price as of April 16, 2018 of $1.06 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until April 16, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 102.07% and an option fair value of $.85 was $42,693. On May 7, 2018, the Company granted one employee a total of 10,000 options to purchase shares of the Company common stock at the closing price as of May 7, 2018 of $0.90 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until May 7, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 101.42% and an option fair value of $.72 was $7,231. On June 1, 2018, the Company granted one employee a total of 10,000 options to purchase shares of the Company common stock at the closing price as of June 1, 2018 of $1.12 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until June 1, 2028. The total estimated value using the Black-Scholes Model, based on a volatility rate of 95.44% and an option fair value of $.87 was $8,705. 2019 On January 7, 2019, the Company granted one employee a total of 10,000 options to purchase shares of the Company common stock at the closing price as of January 7, 2019 of $1.17 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until January 7, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.82% and an option fair value of $.88 was $8,821. On January 21, 2019, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at the closing price as of January 21, 2019 of $1.17 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until January 21, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.75% and an option fair value of $.88 was $13,239. On February 12, 2019, the Company granted one employee a total of 150,000 options to purchase shares of the Company common stock at the closing price as of February 12, 2019 of $1.00 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until February 12, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.79% and an option fair value of $.75 was $113,046. On February 18, 2019, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at the closing price as of February 18, 2019 of $1.05 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until February 18, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.88% and an option fair value of $.84 was $12,537. On February 25, 2019, the Company granted one employee a total of 50,000 options to purchase shares of the Company common stock at the closing price as of February 25, 2019 of $1.00 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until February 25, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.88% and an option fair value of $.75 was $37,697. On March 11, 2019, the Company granted one employee a total of 50,000 options to purchase shares of the Company common stock at the closing price as of March 11, 2019 of $1.00 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until March 11, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.90% and an option fair value of $.75 was $37,688. On May 17, 2019, the Company granted three employees a total of 1,775,000 options to purchase shares of the Company common stock at the closing price as of May 17, 2019 of $1.04 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until May 17, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 80.17% and an option fair value of $.72 was $1,283,178. On August 21, 2019, the Company granted four employees a total of 140,000 options to purchase shares of the Company common stock at the closing price as of August 21, 2019 of $0.95 per share. The Option Shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until August 21, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 80.17% and an option fair value of $.65 was $91,537. On October 21, 2019, the Company granted one employee 150,000 options to purchase shares of the Company common stock at the closing price as of October 21, 2019 of $0.98 per share. The Option Shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until October 21, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.18% and an option fair value of $.64 was $96,165. On November 19, 2019, the Company granted twelve employees a total of 237,500 options to purchase shares of the Company common stock at the closing price as of November 19, 2019 of $0.88 per share. The Option Shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until November 19, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 78.70% and an option fair value of $.60 was $142,409. Stock-based Compensation Expense The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2019 and 2018 was as follows: Years ended December 31, 2019 2018 General and administrative $ 670,188 $ 311,303 Sales and marketing 74,229 225,275 Engineering, research, and development 155,475 131,334 $ 899,892 $ 667,912 As of December 31, 2019, there was approximately $1,568,273 of unearned stock-based compensation that will be expensed from 2020 through 2024. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel all or a portion of the remaining unearned stock-based compensation expense. Future unearned stock-based compensation will increase to the extent we grant additional equity awards. Stock Option Valuation Assumptions We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2019 and 2018: Years ended December 31, 2019 2018 Risk-free interest rate 1.49% to 2.65% 2.24% to 3.10% Expected life (years) 6.00 6.06 Dividend yield - - Expected volatility 74.18% to 90.90% 90.88% to 104.06% The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2019 and 2018 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2019 and 2018: Shares Weighted Average Weighted Average Aggregate Outstanding at December 31, 2017 662,800 $ 0.72 0.70 $ 795,360 Awarded - $ - - $ - Released - $ - - $ - Canceled/forfeited/expired - $ - - $ - Outstanding at December 31, 2018 662,800 $ 0.72 - $ 785,418 Awarded 489,448 $ 1.04 - $ 325,044 Released - $ - - $ - Canceled/forfeited/expired - $ - - $ - Outstanding at December 31, 2019 1,152,248 $ 0.86 - $ 1,120,404 Vested at December 31, 2018 1,152,248 $ - - $ 1,152,248 Unvested at December 31, 2018 - $ - - $ - Unrecognized expense at December 31, 2018 $ - 2019 On January 1, 2019, the Company issued to four independent directors a total of 222,224 restricted stock units. These restricted stock units were issued for the $260,000 of board compensation earned in 2018. The units were valued at $260,000 or $1.17 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) January 1, 2022, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On March 31, 2019, the Company granted four independent directors a total of 72,224 restricted stock units. The units were valued at $65,001 or $0.90 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 31, 2022, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On December 31, 2019, the Company granted four independent directors a total of 195,000 restricted stock units. The units were valued at $195,000 or $1.00 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 31, 2022, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. 2018 In the twelve months ended December 31, 2018, the Company did not issue and restricted stock units. In the twelve months ended December 31, 2018, the company recorded $37,249 in restricted stock units amortization and $260,000 in board compensation. Restricted Stock Unit Compensation Expense The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2019 and 2018 was as follows: Years ended December 31, 2019 2018 General and administrative $ 263,378 $ 297,249 $ 263,378 $ 297,249

10. Warrants to Purchase Common

10. Warrants to Purchase Common Stock	12 Months Ended
	Dec. 31, 2019
Warrants and Rights Note Disclosure [Abstract]
10. Warrants to Purchase Common Stock	10. Warrants to Purchase Common Stock The following table summarizes investor warrant activity as of and for the years ended December 31, 2019 and 2018: Shares Weighted Weighted Outstanding at December 31, 2017 5,134,349 $ 1.19 2.17 Granted - $ - - Exercised (2,127,804) $ - - Canceled/forfeited/expired (894,485) $ - - Outstanding at December 31, 2018 2,112,060 $ 1.19 1.17 Granted 2,691,459 $ - - Exercised - $ - - Canceled/forfeited/expired (1,445,060) $ - - Outstanding at December 31, 2019 3,358,459 $ 1.23 1.27 We did not record any stock-based compensation expense for the years ended December 31, 2019 and 2018, respectively in connection with the exercise of investor-based warrants. Warrants Exercised in 2018 Between January 19, 2018 and March 31, 2018, we conducted an offer to the holders of our outstanding common stock purchase warrants pursuant to which our warrant holders were permitted to exercise their warrants at a reduced exercise price for a period expiring on March 31, 2018. At the commencement of the warrant offer, there were warrants outstanding that entitled their holders to purchase 5,134,349 shares of our common stock at exercise prices of $1.00 and $1.20 per share. Pursuant to the offer, warrant holders exercised warrants to purchase 2,018,125 shares of our common stock, resulting in additional capital of $2,018,125. We undertook this limited-time warrant exercise price reduction in order to raise additional capital without incurring further potential dilution to our stockholders. In addition, through the warrant holders’ acceptance of our offer, we significantly reduced the number of outstanding warrants and thereby simplified our capital structure. The warrant offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. In addition, during the twelve months ended December 31, 2018, warrant holders exercised warrants to purchase 84,679 shares of common stock at $1.20, resulting in additional capital of $101,615 and 50,000 warrants were exercised in cashless exercises resulting in the issuance of 10,234 shares of common stock.

11. Income Taxes

11. Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
11. Income Taxes	11. Income Taxes For the years ended December 31, 2019 and 2018 the provisions for income taxes were as follows: 2019 2018 Federal – current $ - $ - State – current - - Foreign – current - - Total $ - $ - Under ASC 740, deferred income tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our net deferred tax assets and liabilities as of December 31, 2019 and 2018 are as follows: 2019 2018 Deferred tax assets (liabilities): Net operating loss carryforwards $ 14,136,000 $ 11,621,000 Stock based compensation 3,877,000 3,551,000 Accrued compensation 34,000 16,000 Depreciation and amortization 4,241,000 4,759,000 Other 5,000 20,000 Total deferred tax assets 22,293,000 19,967,000 Valuation allowance for net deferred tax assets (22,293,000) (19,967,000) Total $ - $ - The Company has provided a valuation allowance against deferred tax assets recorded as of December 31, 2019 and 2018 due to uncertainties regarding the realization of such assets. The net change in the total valuation allowance for the year ended December 31, 2019 was an increase of approximately $2,326,000. The net change in the total valuation allowance for the year ended December 31, 2018 was an increase of approximately $2,088,000. In assessing the valuation of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. The Company considers projected future taxable income and planning As of December 31, 2019, the Company has available net operating loss carryforwards of approximately $51,000,000 for federal income tax purposes, which will start to expire in 2026. The net operating loss carryforwards for state purposes are approximately $51,000,000 and will start to expire in 2028. The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2019 and 2018 was as follows: 2019 2018 Computed expected tax expense $ (1,853,000) $ (1,515,000) State taxes, net of federal benefit (581,000) (630,000) Expiration of NOL carryforwards 44,000 44,000 Other 64,000 13,000 Change in valuation allowance 2,326,000 2,088,000 Total $ - $ - The Company has determined that during 2010 it experienced a “change of ownership” as defined by Section 382 of the Internal Revenue Code. As such, utilization of net operating loss carryforwards and credits generated before the 2010 change in ownership will be limited to approximately $207,000 per year until such carryforwards are fully utilized. The pre change net operating loss carryforward was approximately $6,000,000. Since 2010 the Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since 2010, utilization of the net operating loss carryforwards tax credit carryforwards would be subject to further annual limitation under Section 382. Any limitation may result in expiration of a portion of the net operating loss carryforwards before utilization. The Company files income tax returns in the U.S. federal jurisdiction, Arizona, and California. Because the Company is carrying forward federal and state net operating losses from 2006, the Company is subject to U.S. federal and state income tax examinations by tax authorities for all years since 2006. The Company does not have a liability for any uncertain tax positions. As of December 31, 2019, no accrued interest or penalties are recorded in the financial statements. On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (“TCJA”), which instituted fundamental changes to the taxation of multinational corporations, including a reduction the U.S. corporate income tax rate to 21% beginning in 2018. As a result, the Company re-measured its deferred tax assets and deferred tax liabilities at the new lower corporate income tax rate and reduced its net deferred tax assets by $7,657,000, with a corresponding net adjustment to the valuation allowance of $7,657,000 for the year ended December 31, 2017. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the TCJA. The Company has recognized the provisional tax impacts related to the revaluation of the deferred tax assets and liabilities and included these amounts in its consolidated financial statements for the year ended December 31, 2017. The ultimate impact may differ from these provisional amounts due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the TCJA. The Company completed the accounting for all of the enacted date income tax effects of the TCJA during 2018. No adjustments were recognized to the provisional amounts recorded at December 31, 2017.

12. Fair Value Measurements of

12. Fair Value Measurements of Financial Instruments	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
12. Fair Value Measurements of Financial Instruments	12. Fair Value Measurements of Financial Instruments The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2019: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ - $ - $ 496,532 $ - Intangibles, net (non-recurring) $ - $ - $ 1,762,211 $ - The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2018: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ - $ - $ 537,550 $ - Intangibles, net (non-recurring) $ - $ - $ 1,781,448 $ - The Company recorded goodwill, intangible assets and an earn-out payable as a result its business combinations, and these assets were valued with the assistance of a valuation consultant and consisted of Level 3 valuation techniques. The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None of these instruments are held for trading purposes.

13. Commitments and Contingenci

13. Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
13. Commitments and Contingencies	13. Commitments and Contingencies Litigation As of the date of this report, there are no pending legal proceedings to which we or our properties are subject, except as described below and for routine litigation incurred in the normal course of business. In February 2019, a complaint was filed against us and five of our employees in the U.S. Federal District Court for the Southern District of New York by mGage, LLC (mGage, LLC v. Glenn Stansbury, et al., No. 19-cv-1165-CM (S.D.N.Y. Filed 2/7/19). In the complaint, the plaintiff alleged that we and five of our employees, who previously worked at mGage, misappropriated confidential information belonging to mGage in violation of the federal Defend Trade Secrets Act, that those same individuals violated non-compete agreements through their employment at Mobivity and that we tortiously interfered with mGage’s business opportunities. On August 14, 2019 we entered into a settlement agreement with mGage pursuant to which we and mGage released each other of all claims and we agreed to pay mGage $300,000 over a period of time. As of December 31, 2019, the settlement has been paid in full. Operating Lease As described in Note 6, the Company has a lease agreement for 10,395 square feet, for its office facilities in Chandler, AZ through December 2020. Monthly rental payments, including common area maintenance charges, are $19,707, to $20,140. As of December 31, 2019, we have an operating lease asset balance for this lease of $194,869 and an operating lease liability balance for this lease of $228,062 recorded in accordance with ASC 840. The Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $2,665 to $2,979 per month, excluding common area maintenance charges. As of December 31, 2019, we have an operating lease asset balance for this lease of $65,776 and an operating lease liability balance for this lease of $75,741 recorded in accordance with ASC 840.

14. Employee Benefit Plan

14. Employee Benefit Plan	12 Months Ended
	Dec. 31, 2019
Retirement Benefits [Abstract]
14. Employee Benefit Plan	14. Employee Benefit Plan The Company has an employee savings plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code (the “Code”), covering all of its employees. Participants in the Plan may contribute a percentage of compensation, but not in excess of the maximum allowed under the Code. The Company may make contributions at the discretion of its Board of Directors. During the years ended December 31, 2019 and 2018, the Company made no contributions to the Plan.

15. Related Party Transactions

15. Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
15. Related Party Transactions	15. Related Party Transactions Unsecured Promissory Note Investments in 2018 During February 2018, we commenced an offer to certain investors, officers and directors of the Company of up to $750,000 in Unsecured Promissory Notes (individually, a “ Note Notes Unsecured Promissory Note Investments in 2019 During the year ended December 31, 2019, we issued to one of our directors, unsecured notes in the principal aggregate amount of $3,500,000, which are due and payable two years after issuance. These notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. We conducted the private placement of our securities in July 2019. The note holder participated in the private placement by converting principal of $2,500,000 and accrued interest under the notes totaling $82,916, into 2,582,916 units of our securities. As of December 31, 2019, we have $1,000,000 as a remaining balance of these notes and accrued interest of $13,958.

16. Subsequent Events

16. Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
16. Subsequent Events	16. Subsequent Events Unsecured Promissory Note Investments in 2020 One February 26, 2020, we issued to one of our directors, unsecured notes in the principal aggregate amount of $200,000, which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this note without notice, subject to a two percent (2%) pre-payment penalty. Warrants Exercised in 2020 On March 2, 2020 one shareholder exercised 234,500 warrants in exchange for 234,500 shares of common stock. This exercise was at the strike price of $1.00 and the company received proceeds of $234,500.

1. The Company and Summary of_2

1. The Company and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
The Company	The Company Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns. Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence. Measure, predict, and boost guest frequency and spend by channel. Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program. Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs. Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Baskin Robbins, Chick-fil-A and Checkers/Rally’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 — - The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands. Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees.
Liquidity	Liquidity We have $273,599 of cash as of December 31, 2019. We had a net loss of $8.8 million for the year then ended, and we used $5.7 million of cash in our operating activities during 2019. Since December 31, 2019 and through the date of this report, we issued an unsecured note in the amount of $200,000, which is due February 2022. This unsecured note alleviated the doubt of a going concern for the Company. Based on our projected 2019 results and, if necessary, our ability to reduce certain variable operating expenses, we believe that our existing capital, and operations, will be sufficient to finance our operations through the first quarter of 2021. If our cash reserves prove insufficient to sustain operations, we plan to raise additional capital by selling shares of capital stock or other equity or debt securities. However, there are no commitments or arrangements for future financings in place at this time, and we can give no assurance that such capital will be available on favorable terms or at all. We may need additional financing thereafter until we can achieve profitability. If we cannot, we will be forced to curtail our operations or possibly be forced to evaluate a sale or liquidation of our assets. Any future financing may involve substantial dilution to existing investors. Although we are actively pursuing financing opportunities, we may not be able to raise cash on terms acceptable to us or at all. There can be no assurance that we will be successful in obtaining additional funding. Financings, if available, may be on terms that are dilutive to our shareholders, and the prices at which new investors would be willing to purchase our securities may be lower than the current price of our ordinary shares. The holders of new securities may also receive rights, preferences or privileges that are senior to those of existing holders of our ordinary shares. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations in the short term.
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The accompanying financial statements are consolidated and include the financial statements of Mobivity Holdings Corp. and our wholly-owned subsidiary. Intercompany transactions are eliminated.
Use of Estimates	Use of Estimates Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management's best knowledge of current events and actions we may undertake in the future. Significant estimates used are those related to: stock-based compensation; valuation of acquired assets, intangible assets and liabilities; useful lives for depreciation and amortization of long-lived assets; future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets; valuation of derivative liabilities; valuation allowance for deferred tax assets; and contingencies. Actual results may ultimately differ from estimates, although management does not generally believe such differences would materially affect the consolidated financial statements in any individual year. However, in regard to ongoing impairment testing of goodwill and indefinite-lived intangible assets, significant deterioration in future cash flow projections or other assumptions used in estimating fair values versus those anticipated at the time of the initial valuations, could result in impairment charges that materially affect the consolidated financial statements in a given year.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.
Acquisitions	Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash and Cash Equivalents	Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2019, and 2018, we recorded an allowance for doubtful accounts of $88,071 and $10,104, respectively. From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred. As of December 31, 2019, we had two customer whose balance represented 53% of total accounts receivable. As of December 31, 2018, we had one customer whose balance represented 34% of total accounts receivable.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2019 and 2018. As a result of these tests, we recorded impairment charges to our goodwill of $0 and $2,288,057 for the years ended December 31, 2019 and 2018, respectively. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. The Company’s evaluation of its long-lived assets completed during the years ended December 31, 2019 and 2018 resulted in no impairment charges.
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset completed during the years ended December 31, 2019 and 2018 resulted in no impairment charges.
Derivative Financial Instruments	Derivative Financial Instruments We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
Going Concern Assumption	Going Concern Assumption These financial statements are prepared on a going concern basis. This requires management to evaluate whether it is probable that known conditions or events, considered in the aggregate, would raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. If such conditions or events are identified, the standard requires management’s mitigation plans to alleviate the doubt or a statement of the substantial doubt about the entity’s ability to continue as a going concern to be disclosed in the financial statements. During management’s evaluation, substantial doubt was raised about the entity’s ability to continue as a going concern. As a result of this evaluation, the Company has undertaken financing efforts (as further described in Note 16) to provide continuing financial support so that the Company is able to pay its debts as and when they fall due. Management has concluded that the doubt raised has been alleviated by the additional financing.
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month to month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”) is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. During the years ended December 31, 2019 and 2018, two customers accounted for 70% and 67% of our revenues, respectively.
Stock-based Compensation	Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures	Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense	Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements and other direct costs. Advertising expense was $40,993 and $88,569 for years ended December 31, 2019 and 2018, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $139,92 and $127,827 of expense related to those activities for the years ended December 31, 2019 and 2018, respectively.
Income Taxes	Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Computation of Net Loss Per Common Share	Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2019 and 2018 which were excluded from the calculation because their effect was anti-dilutive. December 31, 2019 2018 Outstanding employee options 5,781,884 5,012,218 Outstanding restricted stock units 1,152,248 662,800 Outstanding warrants 3,358,459 2,087,060 10,292,591 7,762,078
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In May 2014, the FASB issued ASU 2014-09 regarding ASC Topic 606, “Revenue from Contracts with Customers.” ASU 2014-09 provides principles for recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14 to defer the effective date by one year with early adoption permitted as of the original effective date. This guidance was effective for the Company for its fiscal year beginning January 1, 2018. The Company adopted the modified retrospective approach to initially apply the update and recognize the remaining contract value at the date of application. In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)”. Under this guidance, an entity is required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. This guidance offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. The Company adopted this standard as of January 1, 2019. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230).” ASU No. 2016-18 requires that restricted cash be included with cash and cash equivalents when reconciling the change in cash flow. This guidance is reflected in these financial statements.

1. The Company and Summary of_3

1. The Company and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Dilutive common stock equivalents	We had the following dilutive common stock equivalents as of December 31, 2019 and 2018 which were excluded from the calculation because their effect was anti-dilutive. December 31, 2019 2018 Outstanding employee options 5,781,884 5,012,218 Outstanding restricted stock units 1,152,248 662,800 Outstanding warrants 3,358,459 2,087,060 10,292,591 7,762,078

2. Acquisitions (Tables)

2. Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2019
Business Combinations [Abstract]
Purchase Price Allocation	The allocation of the purchase price to assets and liabilities based upon fair value determinations was as follows: Estimated Tangible and Intangible Net Assets Accounts receivable, net $ 9,400 Property and equipment 21,522 Other current assets & Prepaid expenses 18,009 IP/Technology/Patents 991,300 Goodwill 2,022,489 Total identifiable assets acquired 3,062,720 Liabilities assumed (62,720) Net assets acquired $ 3,000,000
Pro Forma Information	The pro forma financial information is not necessarily indicative of the operating results that would have occurred if the acquisition been consummated as of the date indicated, nor are they necessarily indicative of future operating results. Mobivity Holdings Corp. Unaudited Pro Forma Condensed Combined Statement of Operations For the Year Ended December 31, 2018 Pro Forma Mobivity Belly Combined Revenues Revenues $ 11,556,536 $ 2,374,846 $ 13,931,382 Cost of revenues 3,932,334 658,999 4,591,333 Gross profit 7,624,202 1,715,847 9,340,049 Operating expenses General and administrative 4,197,539 542,136 4,739,675 Sales and marketing 3,931,469 71,543 4,003,012 Engineering, research, and development 3,713,787 64,699 3,778,486 Goodwill impairment 2,288,057 - 2,288,057 Depreciation and amortization 486,255 18,926 505,181 Total operating expenses 14,617,107 697,304 15,314,411 Income (loss) from operations (6,992,905) 1,018,543 (5,974,362) Other income/(expense) Interest income 4,145 - 4,145 Interest expense (210,422) - (210,422) Gain on sale of fixed assets (8,722) - (8,722) Other income - 20,678 20,678 Foreign currency (loss) gain (7,745) - (7,745) Total other income/(expense) (222,744) 20,678 (202,066) Income (loss) before income taxes (7,215,649) 1,039,221 (6,176,428) Income tax expense - - - Net Income (loss) (7,215,649) 1,039,221 (6,176,428) Other comprehensive income (loss), net of income tax Foreign currency translation adjustments 70,523 - 70,523 Comprehensive income (loss) $ (7,145,126) $ 1,039,221 $ (6,105,905) Net loss per share: Basic and diluted $ (0.17) $ (0.15) Weighted average number of shares: Basic and diluted 42,133,368 42,133,368

3. New Accounting Standards (Ta

3. New Accounting Standards (Tables)	12 Months Ended
	Dec. 31, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Financial Statement Impact of Transition to ASC 606	As a result of applying the modified retrospective method to transition to ASC 606, the following adjustments were made to the consolidated balance sheet as of January 1, 2018: December 31, Adjusted 2017 Adjustments January 1, As Reported due to ASC 606 2018 ASSETS Current assets Cash $ 460,059 $ - $ 460,059 Accounts receivable, net of allowance for doubtful accounts of $2,280 885,743 544,599 1,430,342 Other current assets 209,536 - 209,536 Total current assets 1,555,338 544,599 2,099,937 Goodwill 803,118 - 803,118 Intangible assets, net 676,436 - 676,436 Accounts receivable, long term - 424,023 424,023 Other assets 88,916 - 88,916 TOTAL ASSETS $ 3,123,808 $ 968,622 $ 4,092,430 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 1,096,003 $ - $ 1,096,003 Accrued interest 1,168 - 1,168 Accrued and deferred personnel compensation 590,500 - 590,500 Deferred revenue and customer deposits 1,429,266 - 1,429,266 Notes payable, net - current maturities 2,236,224 - 2,236,224 Other current liabilities 226,355 191,121 417,476 Total current liabilities 5,579,516 191,121 5,770,637 Non-current liabilities Notes payable, net - long term 180,810 - 180,810 Other long term liabilities - 150,477 150,477 Total non-current liabilities 180,810 150,477 331,287 Total liabilities 5,760,326 341,598 6,101,924 Commitments and Contingencies (See Note 9) Stockholders' equity Common stock, $0.001 par value; 100,000,000 shares authorized; 37,025,140 and 37,025,140, shares issued and outstanding 37,025 - 37,025 Equity payable 100,862 - 100,862 Additional paid-in capital 77,910,842 - 77,910,842 Accumulated other comprehensive loss (65,764) - (65,764) Accumulated deficit (80,619,483) 627,024 (79,992,459) Total stockholders' equity (2,636,518) 627,024 (2,009,494) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,123,808 $ 968,622 $ 4,092,430 The following tables reflect the impact of adoption of ASC 606 on our condensed consolidated statements of operations for the year ended December 31, 2018 and our condensed consolidated balance sheet as of December 31, 2018 and the amounts as if the Previous Standards were in effect (“Amounts Under Previous Standards”): Condensed Consolidated Statement of Operations Twelve Months Ended December 31, 2018 As reported Total Adjustments Under ASC 606 Amounts Under Previous Standards Revenues Revenues $ 11,556,536 $ 2,692,692 $ 8,863,844 Cost of revenues 3,932,334 - 3,932,334 Gross profit 7,624,202 2,692,692 4,931,510 Operating expenses General and administrative 4,155,636 148,287 4,007,349 Sales and marketing 3,931,469 - 3,931,469 Engineering, research, and development 3,713,787 1,334,582 2,379,205 Depreciation and amortization 486,255 - 486,255 Total operating expenses 12,287,147 1,482,869 10,804,278 Income (loss) from operations (4,662,944) 1,209,823 (5,872,768) Other income/(expense) Interest income 4,145 - 4,145 Interest expense (210,422) - (210,422) Goodwill impairment (2,288,057) - (2,288,057) Loss on sale of fixed assets (8,722) (8,722) Loss on conversion of debt (41,903) (41,903) Foreign currency loss (7,745) - (7,745) Total other income/(expense) (2,552,704) - (2,552,704) Income (loss) before income taxes (7,215,649) 1,209,823 (8,425,472) Income tax expense - - - Net income (loss) (7,215,649) 1,209,823 (8,425,472) Other comprehensive income (loss), net of income tax Foreign currency translation adjustments 70,523 - 70,523 Comprehensive income (loss) $ (7,145,126) $ 1,209,823 $ (8,354,949) Net income (loss) per share: Basic $ (0.17) $ 0.03 $ (0.20) Weighted average number of shares outstanding: Basic 42,133,368 42,133,368 42,133,368 Condensed Consolidated Balance Sheet December 31, 2018 As Reported Total Adjustments Under ASC 606 Amounts Under Previous Standards ASSETS Current assets Cash $ 554,255 $ - $ 554,255 Accounts receivable, net of allowance for doubtful accounts of $9,828 601,658 - 601,658 Contracts receivable, current 578,869 (578,869) - Other current assets 736,309 - 736,309 Total current assets 2,471,091 (578,869) 1,892,222 Goodwill 537,550 - 537,550 Intangible assets, net 1,781,448 - 1,781,448 Contracts receivable, long term 2,113,823 (2,113,823) - Other assets 527,146 - 527,146 TOTAL ASSETS $ 7,431,058 $ (2,692,692) $ 4,738,366 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 1,731,628 $ - $ 1,731,628 Accrued interest 9,167 - 9,167 Accrued and deferred personnel compensation 350,311 - 350,311 Deferred revenue and customer deposits 1,956,938 - 1,956,938 Notes payable, net - current maturities 1,279,590 - 1,279,590 Other current liabilities 723,636 (622,369) 101,267 Total current liabilities 6,051,270 (622,369) 5,428,901 Non-current liabilities Notes payable, net - long term 194,328 - 194,328 Other long term liabilities 860,500 (860,500) Total non-current liabilities 1,054,828 (860,500) 194,328 Total liabilities 7,106,098 (1,482,869) 5,623,229 Commitments and Contingencies (See Note 9) Stockholders' equity Common stock, $0.001 par value; 100,000,000 shares authorized; 45,998,053 and 45,998,053, shares issued and outstanding 45,998 - 45,998 Equity payable 100,862 - 100,862 Additional paid-in capital 88,008,473 - 88,008,473 Accumulated other comprehensive loss 4,759 - 4,759 Accumulated deficit (87,835,132) (1,209,823) (89,044,955) Total stockholders' equity 324,960 (1,209,823) (884,863) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 7,431,058 $ (2,692,692) $ 4,738,366

4. Goodwill and Intangible As_2

4. Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	The following table presents goodwill and impairment for the years ended December 31, 2019 and 2018: Goodwill December 31, 2017 $ 803,118 Acquired 2,022,489 Impairment (2,288,057) December 31, 2018 537,550 Acquired (41,198) Impairment - December 31, 2019 $ 496,352
Intangible Assets	The following table presents components of identifiable intangible assets for the years ended December 31, 2019 and 2018: December 31, 2019 December 31, 2018 Gross Accumulated Net Carrying Weighted Gross Accumulated Net Carrying Weighted Patents and trademarks $ 183,583 $ (113,730) $ 69,853 14 $ 177,944 $ (72,957) $ 104,987 15 Customer and merchant 2,321,112 (1,581,876) 739,236 10 2,343,112 (1,507,024) 836,088 10 Trade name 197,924 (147,192) 50,732 10 197,868 (137,872) 59,996 10 Acquired technology 684,540 (539,748) 144,792 10 684,540 (523,448) 161,092 10 Non-compete agreement 79,299 (18,368) 60,931 2 79,299 (2,508) 76,791 2 $ 3,466,458 $ (2,400,914) $ 1,065,544 $ 3,482,763 $ (2,243,809) $ 1,238,954
Future Amortization Intangible Assets	Expected future intangible asset amortization as of December 31, 2019 is as follows: Year ending December 31, Amount 2020 $ 150,737 2021 148,045 2022 147,868 2023 145,359 2024 108,764 Thereafter 364,771 Total $ 1,065,544

5. Software Development Costs (

5. Software Development Costs (Tables)	12 Months Ended
	Dec. 31, 2019
Research and Development [Abstract]
Software Development Costs	The following table presents details of our software development costs for the years ended December 31, 2019 and 2018: December 31, 2019 December 31, 2018 Gross Accumulated Net Carrying Weighted Gross Accumulated Net Carrying Weighted $ 2,245,811 $ (1,549,144) $ 696,667 2 $ 1,781,902 $ (1,239,408) $ 542,494 2 $ 2,245,811 $ (1,549,144) $ 696,667 $ 1,781,902 $ (1,239,408) $ 542,494
Future Amortization Software	The estimated future amortization expense of software development costs as of December 31, 2019 is as follows: Year ending December 31, Amount 2019 $ 479,188 2020 217,092 2021 398 2022 - 2023 - Thereafter - Total $ 696,667

6. Operating Lease Assets (Tabl

6. Operating Lease Assets (Tables)	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Additional details related to leases on Balance Sheet	The following are additional details related to leases recorded on our balance sheet as of December 31, 2019: Leases Classification Amount Assets Operating lease assets Operating lease assets $ 260,645 Total lease assets $ 260,645 Liabilities Current Operating lease liabilities Operating lease liabilities $ 258,343 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 45,460 Total lease liabilities $ 303,803
Schedule of Minimum Lease Payments	he maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2020 $ 270,982 2021 35,748 2022 11,916 2023 - 2024 - Thereafter - Total future lease payments 318,646 Less: imputed interest (14,843) Total $ 303,803 Weighted Average Remaining Lease Term (years) Operating leases 1.34 Weighted Average Discount Rate 6.75%

7. Notes Payable and Interest_2

7. Notes Payable and Interest Expense (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Schedule of notes payable	The following table presents details of our notes payable as of December 31, 2019 and 2018: Facility Maturity Interest Rate Balance at Balance at BDC Term Loan October 15, 2021 25 % $ 224,307 $ 252,837 ACOA Note May 1, 2021 - 117,131 141,081 Wintrust Bank November 1, 2021 Prime + 1.5 % 766,667 1,000,000 Related Party Note March 31, 2020 15 % 1,140,700 80,000 Total Debt 2,248,805 1,473,918 Less current portion (681,276) (1,279,590) Long-term debt, net of current portion $ 1,567,529 $ 194,328
Schedule of principal payments on note payables	Principal payments on notes payables are due as follows: Year ending December 31, Amount 2020 $ 681,276 2021 1,521,070 2022 37,971 2023 8,488 2024 - Thereafter - Total future debt payments 2,248,805
Summary of Interest Expense	The following table summarizes interest expense for the years ended December 31, 2019 and 2018: December 31, 2019 2018 Interest expense $ 236,706 $ 210,422 Total interest expense $ 236,706 $ 210,422

9. Stock-based Plans and Stoc_2

9. Stock-based Plans and Stock-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Activity	The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2019 and 2018: Shares Weighted Weighted Aggregate Outstanding at December 31, 2017 6,818,948 $ 1.06 8.12 $ 209,690 Granted 855,000 $ 1.25 - $ - Exercised (37,292) 0.57 Forfeit/canceled (1,566,589) $ 0.74 - $ - Expired (1,082,641) $ 1.18 - $ - Outstanding at December 31, 2018 4,987,426 $ 1.16 7.12 $ 1,215,067 Granted 2,592,500 $ 1.01 - $ - Exercised - $ - - $ - Forfeit/canceled (923,389) $ 1.00 - $ - Expired (874,653) $ 0.93 - $ - Outstanding at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868 Expected to vest at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868 Exercisable at December 31, 2019 3,339,437 $ 1.29 5.76 $ 343,255 Unrecognized expense at December 31, 2019 $ 1,568,273
Stock-Based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2019 and 2018 was as follows: Years ended December 31, 2019 2018 General and administrative $ 670,188 $ 311,303 Sales and marketing 74,229 225,275 Engineering, research, and development 155,475 131,334 $ 899,892 $ 667,912
Valuation Assumptions	We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2019 and 2018: Years ended December 31, 2019 2018 Risk-free interest rate 1.49% to 2.65% 2.24% to 3.10% Expected life (years) 6.00 6.06 Dividend yield - - Expected volatility 74.18% to 90.90% 90.88% to 104.06%
Restricted Stock Units R S U [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2019 and 2018 was as follows: Years ended December 31, 2019 2018 General and administrative $ 263,378 $ 297,249 $ 263,378 $ 297,249
Restricted Stock Unit Activity	The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2019 and 2018: Shares Weighted Average Weighted Average Aggregate Outstanding at December 31, 2017 662,800 $ 0.72 0.70 $ 795,360 Awarded - $ - - $ - Released - $ - - $ - Canceled/forfeited/expired - $ - - $ - Outstanding at December 31, 2018 662,800 $ 0.72 - $ 785,418 Awarded 489,448 $ 1.04 - $ 325,044 Released - $ - - $ - Canceled/forfeited/expired - $ - - $ - Outstanding at December 31, 2019 1,152,248 $ 0.86 - $ 1,120,404 Vested at December 31, 2018 1,152,248 $ - - $ 1,152,248 Unvested at December 31, 2018 - $ - - $ - Unrecognized expense at December 31, 2018 $ -

10. Warrants to Purchase Comm_2

10. Warrants to Purchase Common Stock (Tables)	12 Months Ended
	Dec. 31, 2019
Warrants and Rights Note Disclosure [Abstract]
Schedule of Warrant Activity	The following table summarizes investor warrant activity as of and for the years ended December 31, 2019 and 2018: Shares Weighted Weighted Outstanding at December 31, 2017 5,134,349 $ 1.19 2.17 Granted - $ - - Exercised (2,127,804) $ - - Canceled/forfeited/expired (894,485) $ - - Outstanding at December 31, 2018 2,112,060 $ 1.19 1.17 Granted 2,691,459 $ - - Exercised - $ - - Canceled/forfeited/expired (1,445,060) $ - - Outstanding at December 31, 2019 3,358,459 $ 1.23 1.27

11. Income Taxes (Tables)

11. Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Provisions for income taxes	For the years ended December 31, 2019 and 2018 the provisions for income taxes were as follows: 2019 2018 Federal – current $ - $ - State – current - - Foreign – current - - Total $ - $ -
Net deferred tax assets and liabilities	Significant components of our net deferred tax assets and liabilities as of December 31, 2019 and 2018 are as follows: 2019 2018 Deferred tax assets (liabilities): Net operating loss carryforwards $ 14,136,000 $ 11,621,000 Stock based compensation 3,877,000 3,551,000 Accrued compensation 34,000 16,000 Depreciation and amortization 4,241,000 4,759,000 Other 5,000 20,000 Total deferred tax assets 22,293,000 19,967,000 Valuation allowance for net deferred tax assets (22,293,000) (19,967,000) Total $ - $ -
Reconciliation of federal statutory income tax rate to our effective income tax rate	The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2019 and 2018 was as follows: 2019 2018 Computed expected tax expense $ (1,853,000) $ (1,515,000) State taxes, net of federal benefit (581,000) (630,000) Expiration of NOL carryforwards 44,000 44,000 Other 64,000 13,000 Change in valuation allowance 2,326,000 2,088,000 Total $ - $ -

12. Fair Value Measurements o_2

12. Fair Value Measurements of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Financial Assets And Liabilities Measured At Fair Value On A Recurring And Non-Recurring Basis	The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2019: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ - $ - $ 496,532 $ - Intangibles, net (non-recurring) $ - $ - $ 1,762,211 $ - The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2018: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ - $ - $ 537,550 $ - Intangibles, net (non-recurring) $ - $ - $ 1,781,448 $ -

1. The Company and Summary of_4

1. The Company and Summary of Significant Accounting Policies (Details)	Mar. 02, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)customer	Dec. 31, 2018USD ($)customer	Dec. 31, 2017USD ($)customer	Feb. 28, 2022USD ($)	Mar. 31, 2018$ / shares
Product Information [Line Items]
Cash including restricted cash		$ 273,599
Net loss		(8,821,974)	$ (7,215,649)
Debt, principal amount		1,000,000			$ 200,000
Accounts receivable, allowance for doubtful accounts		88,071	10,104	$ 2,280
Impairment charges on evaluation of goodwill		0	2,288,057
Impairment charges on long-lived assets		0	0
Advertising expense		40,993	88,569
Marketing expense		$ 139,392	$ 127,827
Warrant Issuance [Member]
Product Information [Line Items]
Warrants outstanding, per share | $ / shares						$ 1
Subsequent Event [Member] | Warrant Issuance [Member]
Product Information [Line Items]
Warrants outstanding, per share | $ / shares	$ 1
Number of warrants exercised | shares	234,500
Proceeds from warrants exercised	$ 234,500
Computer Software Intangible Asset [Member]
Product Information [Line Items]
Estimated useful lives		2 years	2 years
Impairment charges on long-lived assets		$ 0	$ 0
Accounts Receivable [Member]
Product Information [Line Items]
Number of significant customers | customer			2	1
Customer concentration risk			53.00%	34.00%
Sales Revenue Net [Member]
Product Information [Line Items]
Number of significant customers | customer		2	2
Customer concentration risk		70.00%	67.00%
Minimum [Member]
Product Information [Line Items]
Estimated useful lives		1 year
Maximum [Member]
Product Information [Line Items]
Estimated useful lives		20 years

1. The Company and Summary of_5

1. The Company and Summary of Significant Accounting Policies (Dilutive Common Stock Equivalents) (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	10,292,591	7,762,078
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	5,781,884	5,012,218
Restricted Stock Units R S U [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	1,152,248	662,800
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	3,358,459	2,087,060

2. Acquisitions (Details)

2. Acquisitions (Details)	Nov. 14, 2018USD ($)itemft²	Feb. 28, 2022USD ($)	Dec. 31, 2019USD ($)
Business Acquisition [Line Items]
Debt, principal amount		$ 200,000	$ 1,000,000
Loan And Security Agreement [Member]
Business Acquisition [Line Items]
Payments to acquire businesses	$ 3,000,000
Debt, principal amount	$ 1,000,000
Debt instrument, term	3 years
Principal payments of debt	$ 33,333
Loan And Security Agreement [Member] | Prime Rate [Member]
Business Acquisition [Line Items]
Basis spread on interest rate	1.50%
Belly Inc. [Member]
Business Acquisition [Line Items]
Number of deployed merchant locations | ft²	5,000
Number of customers | item	7

2. Acquisitions (Purchase Price

2. Acquisitions (Purchase Price Allocation) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Nov. 14, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Goodwill	$ 496,352	$ 537,550		$ 803,118
Certain Belly Inc. [Member]
Business Acquisition [Line Items]
Accounts receivable, net			$ 9,400
Property and equipment			21,522
Other assets			18,009
IP/Technology/Patents			991,300
Goodwill			2,022,489
Total assets acquired			3,062,720
Liabilities assumed			(62,720)
Net assets acquired			$ 3,000,000

2. Acquisitions (Pro Forma Info

2. Acquisitions (Pro Forma Information) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues
Revenues	$ 10,056,922	$ 11,556,536
Cost of revenues	5,938,298	3,932,334
Gross profit	4,118,624	7,624,202
Operating expenses
General and administrative	5,588,329	4,155,636
Sales and marketing	2,707,356	3,931,469
Engineering, research, and development	3,609,968	3,713,787
Goodwill impairment	0	2,288,057
Depreciation and amortization	600,066	486,255
Total operating expenses	12,505,719	12,287,147
Loss from operations	(8,387,095)	(4,662,945)
Other income/(expense)
Interest income	28,160	4,145
Interest expense	(236,706)	(210,422)
Foreign currency gain/(loss)	6,129	(7,745)
Total other income/(expense)		(2,552,704)
Loss before income taxes	(8,821,974)	(7,215,649)
Income tax expense	0	0
Net loss	(8,821,974)	(7,215,649)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments	4,021	70,523
Comprehensive loss	$ (8,817,953)	$ (7,145,126)
Net income (loss) per share:
Basic and diluted	$ (0.18)	$ (0.17)
Weighted average number of shares:
Basic and diluted	47,720,507	42,133,368
Pro Form Combined [Member]
Revenues
Revenues		$ 13,931,382
Cost of revenues		4,591,333
Gross profit		9,340,049
Operating expenses
General and administrative		4,739,675
Sales and marketing		4,003,012
Engineering, research, and development		3,778,486
Goodwill impairment		2,288,057
Depreciation and amortization		505,181
Total operating expenses		15,314,411
Loss from operations		(5,974,362)
Other income/(expense)
Interest income		4,145
Interest expense		(210,422)
Gain on sale of fixed assets		(8,722)
Other income		20,678
Foreign currency gain/(loss)		(7,745)
Total other income/(expense)		(202,066)
Loss before income taxes		(6,176,428)
Income tax expense		0
Net loss		(6,176,428)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments		70,523
Comprehensive loss		$ (6,105,905)
Net income (loss) per share:
Basic and diluted		$ (0.15)
Weighted average number of shares:
Basic and diluted		42,133,368
Belly [Member]
Revenues
Revenues		$ 2,374,846
Cost of revenues		658,999
Gross profit		1,715,847
Operating expenses
General and administrative		542,136
Sales and marketing		71,543
Engineering, research, and development		64,699
Goodwill impairment		0
Depreciation and amortization		18,926
Total operating expenses		697,304
Loss from operations		1,018,543
Other income/(expense)
Interest income		0
Interest expense		0
Gain on sale of fixed assets		0
Other income		20,678
Foreign currency gain/(loss)		0
Total other income/(expense)		20,678
Loss before income taxes		1,039,221
Income tax expense		0
Net loss		1,039,221
Other comprehensive loss, net of income tax
Foreign currency translation adjustments		0
Comprehensive loss		1,039,221
Mobivity [Member]
Revenues
Revenues		11,556,536
Cost of revenues		3,932,334
Gross profit		7,624,202
Operating expenses
General and administrative		4,197,539
Sales and marketing		3,931,469
Engineering, research, and development		3,713,787
Goodwill impairment		2,288,057
Depreciation and amortization		486,255
Total operating expenses		14,617,107
Loss from operations		(6,992,905)
Other income/(expense)
Interest income		4,145
Interest expense		(210,422)
Gain on sale of fixed assets		(8,722)
Other income		0
Foreign currency gain/(loss)		(7,745)
Total other income/(expense)		(222,744)
Loss before income taxes		(7,215,649)
Income tax expense		0
Net loss		(7,215,649)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments		70,523
Comprehensive loss		$ (7,145,126)
Net income (loss) per share:
Basic and diluted		$ (0.17)
Weighted average number of shares:
Basic and diluted		42,133,368

3. New Accounting Standards (Ef

3. New Accounting Standards (Effect on Balance Sheet) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Jan. 02, 2018	Dec. 31, 2017
Current assets
Cash	$ 273,599	$ 554,255		$ 460,059
Accounts receivable, net of allowance for doubtful accounts of $9,828	614,726	601,658		885,743
Contracts receivable, current	526,948	578,869		0
Other current assets	601,749	736,309		209,536
Total current assets	2,017,022	2,471,091		1,555,338
Goodwill	496,352	537,550		803,118
Intangible assets, net	1,762,211	1,781,448		676,436
Contracts receivable, long term	1,260,371	2,113,823		0
Other assets	67,787	527,146		88,916
TOTAL ASSETS	5,864,388	7,431,058		3,123,808
Current liabilities
Accounts payable	3,256,888	1,731,628		1,096,003
Accrued interest	35,292	9,167		1,168
Accrued and deferred personnel compensation	244,953	350,311		590,500
Deferred revenue and customer deposits	440,309	1,956,938		1,429,266
Notes payable, net - current maturities	540,576	1,148,198		2,236,224
Other current liabilities	566,808	723,636		226,355
Total current liabilities	5,225,526	6,051,270		5,579,516
Non-current liabilities
Notes payable, net - long term	567,529	194,328		180,810
Other long term liabilities	785,678	860,500		0
Total non-current liabilities	2,353,207	1,054,828		180,810
Total liabilities	7,578,733	7,106,098		5,760,326
Commitments and Contingencies (See Note 9)	0	0
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized; 45,904,948 and 45,904,948, shares issued and outstanding	51,381	45,998		37,025
Equity payable	100,862	100,862		100,862
Additional paid-in capital	94,781,738	88,008,473		77,910,842
Accumulated other comprehensive loss	8,780	4,759		(65,764)
Accumulated deficit	(96,657,106)	(87,835,132)		(80,619,483)
Total stockholders' (deficit) equity	(1,714,345)	324,960		(2,636,518)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 5,864,388	7,431,058		3,123,808
Calculated Under Revenue Guidance In Effect Before Topic606 [Member]
Current assets
Cash		554,255	$ 460,059
Accounts receivable, net of allowance for doubtful accounts of $9,828		601,658	1,430,342
Contracts receivable, current		0
Other current assets		736,309	209,536
Total current assets		1,892,222	2,099,937
Goodwill		537,550	803,118
Intangible assets, net		1,781,448	676,436
Contracts receivable, long term		0	424,023
Other assets		527,146	88,916
TOTAL ASSETS		4,738,366	4,092,430
Current liabilities
Accounts payable		1,731,628	1,096,003
Accrued interest		9,167	1,168
Accrued and deferred personnel compensation		350,311	590,500
Deferred revenue and customer deposits		1,956,938	1,429,266
Notes payable, net - current maturities		1,279,590	2,236,224
Other current liabilities		101,267	417,476
Total current liabilities		5,428,901	5,770,637
Non-current liabilities
Notes payable, net - long term		194,328	180,810
Other long term liabilities		0	150,477
Total non-current liabilities		194,328	331,287
Total liabilities		5,623,229	6,101,924
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized; 45,904,948 and 45,904,948, shares issued and outstanding		45,998	37,025
Equity payable		100,862	100,862
Additional paid-in capital		88,008,473	77,910,842
Accumulated other comprehensive loss		4,759	(65,764)
Accumulated deficit		(89,044,955)	(79,992,459)
Total stockholders' (deficit) equity		(884,863)	(2,009,494)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		4,738,366	$ 4,092,430
Restatement Adjustment [Member] | Difference Between Revenue Guidance In Effect Before And After Topic606 [Member]
Current assets
Cash		0		0
Accounts receivable, net of allowance for doubtful accounts of $9,828		0		544,599
Contracts receivable, current		(578,869)
Other current assets		0		0
Total current assets		(578,869)		544,599
Goodwill		0		0
Intangible assets, net		0		0
Contracts receivable, long term		(2,113,823)		424,023
Other assets		0		0
TOTAL ASSETS		(2,692,692)		968,622
Current liabilities
Accounts payable		0		0
Accrued interest		0		0
Accrued and deferred personnel compensation		0		0
Deferred revenue and customer deposits		0		0
Notes payable, net - current maturities		0		0
Other current liabilities		(622,369)		191,121
Total current liabilities		(622,369)		191,121
Non-current liabilities
Notes payable, net - long term		0		0
Other long term liabilities		(860,500)		150,477
Total non-current liabilities		(860,500)		150,477
Total liabilities		(1,482,869)		341,598
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized; 45,904,948 and 45,904,948, shares issued and outstanding		0		0
Equity payable		0		0
Additional paid-in capital		0		0
Accumulated other comprehensive loss		0		0
Accumulated deficit		(1,209,823)		627,024
Total stockholders' (deficit) equity		(1,209,823)		627,024
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$ (2,692,692)		$ 968,622

3. New Accounting Standards (_2

3. New Accounting Standards (Effect on Balance Sheet Additional Information) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Jan. 02, 2018	Dec. 31, 2017
Accounts receivable, allowance for doubtful accounts	$ 88,071	$ 10,104		$ 2,280
Common stock, par value	$ 0.001	$ 0.001		$ 0.001
Common stock, shares authorized	100,000,000	100,000,000		100,000,000
Common stock, shares issued	51,380,969	45,998,053		37,025,140
Common stock, shares outstanding	51,380,969	45,998,053		37,025,140
Calculated Under Revenue Guidance In Effect Before Topic606 [Member]
Accounts receivable, allowance for doubtful accounts			$ 2,280
Common stock, par value			$ 0.001
Common stock, shares authorized			100,000,000
Common stock, shares issued			37,025,140
Common stock, shares outstanding			37,025,140

3. New Accounting Standards (_3

3. New Accounting Standards (Effect on Statement of Operations) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues
Revenues	$ 10,056,922	$ 11,556,536
Cost of revenues	5,938,298	3,932,334
Gross profit	4,118,624	7,624,202
Operating expenses
General and administrative	5,588,329	4,155,636
Sales and marketing	2,707,356	3,931,469
Engineering, research, and development	3,609,968	3,713,787
Depreciation and amortization	600,066	486,255
Total operating expenses	12,505,719	12,287,147
Income (loss) from operations	(8,387,095)	(4,662,945)
Other income/(expense)
Interest income	28,160	4,145
Interest expense	(236,706)	(210,422)
Goodwill impairment	0	2,288,057
Loss on sale of fixed assets	0	(8,722)
Loss on conversion of debt	232,462	41,903
Foreign currency (loss) gain	6,129	(7,745)
Total other income/(expense)		(2,552,704)
Income (loss) before income taxes	(8,821,974)	(7,215,649)
Income tax expense	0	0
Net Income (loss)	(8,821,974)	(7,215,649)
Other comprehensive income (loss), net of income tax
Foreign currency translation adjustments	4,021	70,523
Comprehensive income (loss)	$ (8,817,953)	(7,145,126)
Calculated Under Revenue Guidance In Effect Before Topic606 [Member]
Revenues
Revenues		2,692,692
Cost of revenues		0
Gross profit		2,692,692
Operating expenses
General and administrative		148,287
Sales and marketing		0
Engineering, research, and development		1,334,582
Depreciation and amortization		0
Total operating expenses		1,482,869
Income (loss) from operations		1,209,823
Other income/(expense)
Interest income		0
Interest expense		0
Goodwill impairment		0
Foreign currency (loss) gain		0
Total other income/(expense)		0
Income (loss) before income taxes		1,209,823
Income tax expense		0
Net Income (loss)		1,209,823
Other comprehensive income (loss), net of income tax
Foreign currency translation adjustments		0
Comprehensive income (loss)		$ 1,209,823
Net income (loss) per share:
Basic		$ 0.03
Weighted average number of shares:
Basic		42,133,368
Difference Between Revenue Guidance In Effect Before And After Topic606 [Member]
Revenues
Revenues		$ 8,863,844
Cost of revenues		3,932,334
Gross profit		4,931,510
Operating expenses
General and administrative		4,007,349
Sales and marketing		3,931,469
Engineering, research, and development		2,379,205
Depreciation and amortization		486,255
Total operating expenses		10,804,278
Income (loss) from operations		(5,872,768)
Other income/(expense)
Interest income		4,145
Interest expense		210,422
Goodwill impairment		(2,288,057)
Loss on sale of fixed assets		(8,722)
Loss on conversion of debt		(41,903)
Foreign currency (loss) gain		(7,745)
Total other income/(expense)		(2,552,704)
Income (loss) before income taxes		(8,425,472)
Income tax expense		0
Net Income (loss)		(8,425,472)
Other comprehensive income (loss), net of income tax
Foreign currency translation adjustments		70,523
Comprehensive income (loss)		$ (8,354,949)
Net income (loss) per share:
Basic		$ (0.20)
Weighted average number of shares:
Basic		42,133,368

4. Goodwill and Intangible As_3

4. Goodwill and Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment	$ 0	$ 2,288,057
Amortization expense	178,653	63,795
Intangible asset impairment	$ 0	$ 0

4. Goodwill and Intangible As_4

4. Goodwill and Intangible Assets : (Goodwill) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, Beginning Balance	$ 537,550	$ 803,118
Acquired	(41,198)	2,022,489
Impairment	0	(2,288,057)
Goodwill, Ending Balance	$ 496,352	$ 537,550

4. Goodwill and Intangible As_5

4. Goodwill and Intangible Assets: (Intangible Assets) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 3,466,458	$ 3,482,763
Accumulated Amortization	(2,400,914)	(2,243,809)
Total	1,065,544	1,238,954
Patents And Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	183,583	177,944
Accumulated Amortization	(113,730)	(72,957)
Total	$ 69,853	$ 104,987
Weighted Average Useful Life (Years)	14 years	15 years
Customer and merchant Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,321,112	$ 2,343,112
Accumulated Amortization	(1,581,876)	(1,507,024)
Total	$ 739,236	$ 836,088
Weighted Average Useful Life (Years)	10 years	10 years
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 197,924	$ 197,868
Accumulated Amortization	(147,192)	(137,872)
Total	$ 50,732	$ 59,996
Weighted Average Useful Life (Years)	10 years	10 years
Acquired technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 684,540	$ 684,540
Accumulated Amortization	(539,748)	(523,448)
Total	$ 144,792	$ 161,092
Weighted Average Useful Life (Years)	10 years	10 years
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 79,299	$ 79,299
Accumulated Amortization	(18,368)	(2,508)
Total	$ 60,931	$ 76,791
Weighted Average Useful Life (Years)	2 years	2 years

4. Goodwill and Intangible As_6

4. Goodwill and Intangible Assets: (Future Amortization Intangible Assets) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 150,737
2021	148,045
2022	147,868
2023	145,359
2024	108,764
Thereafter	364,771
Total	$ 1,065,544	$ 1,238,954

5. Software Development Costs_2

5. Software Development Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 178,653	$ 63,795
Computer Software Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 309,736	$ 326,631
Estimated useful lives	2 years	2 years
Intangible asset impairment	$ 0	$ 0

5. Software Development Costs_

5. Software Development Costs: (Software Development Costs) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,245,811	$ 1,781,902
Accumulated Amortization	(1,549,144)	(1,239,408)
Net Carrying Amount	696,667	542,495
Computer Software Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,245,811	1,781,902
Accumulated Amortization	(1,549,144)	(1,239,408)
Net Carrying Amount	$ 696,667	$ 542,495
Weighted Average Useful Life (Years)	2 years	2 years

5. Software Development Costs_3

5. Software Development Costs: (Future Amortization Software) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
2019	$ 150,737
2020	148,045
2021	147,868
2022	145,359
2023	108,764
Thereafter	364,771
Total	1,065,544	$ 1,238,954
Computer Software Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
2019	479,188
2020	217,092
2021	398
2022	0
2023	0
Thereafter	0
Total	$ 696,667

6. Operating Lease Assets (Deta

6. Operating Lease Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Amortization expense	$ 4,419
Rent expense	$ 320,496	$ 416,080

6. Operating Lease Assets_ (Add

6. Operating Lease Assets: (Additional details related to leases of Balance Sheet) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Assets
Operating lease assets	$ 260,645	$ 0
Operating Lease
Assets
Operating lease assets	260,645
Total lease assets	260,645
Current
Operating lease liabilities	258,343
Noncurrent
Operating lease liabilities	45,460
Total lease liabilities	$ 303,803

6. Operating Lease Assets _ (Sc

6. Operating Lease Assets : (Schedule of Minimum Lease Payments) (Details)	Dec. 31, 2019USD ($)
Operating Lease
2020	$ 270,982
2021	35,748
2022	11,916
2023	0
2024	0
Thereafter	0
Total future lease payments	318,646
Less: imputed interest	(14,843)
Total	$ 303,803
Weighted Average Remaining Lease Term (years) Operating leases	1 year 4 months 2 days
Weighted Average Discount Rate Operating leases	6.75%

7. Notes Payable and Interest_3

7. Notes Payable and Interest Expense (Details) - USD ($)

May 01, 2023

Nov. 01, 2021

May 15, 2021

Nov. 15, 2020

Nov. 01, 2020

May 15, 2020

Nov. 15, 2019

Nov. 01, 2019

Aug. 15, 2019

Nov. 14, 2018

Nov. 06, 2017

Apr. 19, 2018

Feb. 28, 2018

Mar. 31, 2016

Sep. 30, 2018

Dec. 31, 2019

Dec. 31, 2018

Feb. 28, 2022

Dec. 31, 2017

Jan. 08, 2016

Debt Instrument [Line Items]

Amortization of deferred financing costs

$ 0

$ 0

Interest expense

236,706

210,422

Debt, principal amount

$ 1,000,000

$ 200,000

Acoa Note [Member]

Debt Instrument [Line Items]

Maturity date

May 1, 2021

Principal payment

$ 2,215

$ 4,500

$ 4,000

$ 3,500

$ 3,000

Bdc Term Loan [Member]

Debt Instrument [Line Items]

Maturity date

Oct. 15, 2021

Amortization of deferred financing costs

856

Debt issuance costs

$ 0

$ 1,529

Stated rate

25.00%

20.00%

Principal payment

$ 16,000

$ 14,000

$ 12,000

$ 10,000

$ 8,500

Svb Working Capital Line Of Credit Facility [Member]

Debt Instrument [Line Items]

Maximum current borrowing capacity

$ 2,000,000

Commitment percentage per annum

0.50%

Debt instrument, term

2 years

Capitalized debt issuance costs

$ 47,287

Amortization of deferred financing costs

$ 27,393

Debt issuance costs

$ 0

Svb Working Capital Line Of Credit Facility [Member] | Minimum [Member] | Prime Rate [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

(1.75%)

Svb Working Capital Line Of Credit Facility [Member] | Maximum [Member] | Prime Rate [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

3.75%

Bridge Loan Promissory Note [Member]

Debt Instrument [Line Items]

Borrowing under Facility

$ 1,000,000

Facility fee

1.00%

Repayment of promissory note

$ 1,000,000

Stated rate

2.00%

Wintrust Loan [Member]

Debt Instrument [Line Items]

Borrowing under Facility

$ 1,000,000

Proceeds from loan re-finance

$ 1,000,000

Wintrust Loan [Member] | Prime Rate [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

1.50%

Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

1.50%

Debt, principal amount

$ 1,080,000

Stated rate

15.00%

Prepayment penalty, interest rate

2.00%

Repayment of related party debt

1,000,000

Related Party Note

80,000

Accrued interest

$ 21,333

Unsecured Promissory Notes [Member] | Maximum [Member]

Debt Instrument [Line Items]

Debt, principal amount

$ 750,000

Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

1.50%

Debt, principal amount

$ 3,500,000

Stated rate

15.00%

Prepayment penalty, interest rate

2.00%

Related Party Note

$ 1,000,000

Accrued interest

13,958

Loss on conversion of debt

232,462

Unsecured Promissory Notes [Member] | Principal

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Amount

2,500,000

Unsecured Promissory Notes [Member] | Accrued interest

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Amount

$ 82,916

7. Notes Payable and Interest_4

7. Notes Payable and Interest Expense: (Schedule of Notes Payable) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jan. 08, 2016
Debt Instrument [Line Items]
Total Debt	$ 2,248,805	$ 1,473,918
Less current portion	(681,276)	(1,279,590)
Long-term debt, net of current portion	$ 1,567,529	194,328
Bdc Term Loan [Member]
Debt Instrument [Line Items]
Maturity date	Oct. 15, 2021
Interest Rate	25.00%		20.00%
Total Debt	$ 224,307	252,837
Acoa Note [Member]
Debt Instrument [Line Items]
Maturity date	May 1, 2021
Total Debt	$ 117,131	141,081
Wintrust Bank [Member]
Debt Instrument [Line Items]
Maturity date	Nov. 1, 2021
Interest Rate	1.50%
Total Debt	$ 766,667	1,000,000
Related Party Note [Member]
Debt Instrument [Line Items]
Maturity date	Mar. 31, 2020
Interest Rate	15.00%
Total Debt	$ 1,140,700	$ 80,000

7. Notes Payable and Interest_5

7. Notes Payable and Interest Expense : (Schedule of principal payments on note payables) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
2020	$ 681,276
2021	1,521,070
2022	37,971
2023	8,488
2024	0
Thereafter	0
Total future debt payments	$ 2,248,805	$ 1,473,918

7. Notes Payable and Interest_6

7. Notes Payable and Interest Expense : (Summary of Interest Expense) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Interest expense	$ 236,706	$ 210,422
Total interest expense	$ 236,706	$ 210,422

8. Common Stock and Equity Pa_2

8. Common Stock and Equity Payable (Details) - USD ($)	Nov. 06, 2018	Feb. 07, 2018	Jul. 31, 2019	Oct. 19, 2018	Aug. 29, 2018	Jun. 30, 2018	Feb. 23, 2018	Sep. 30, 2019	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Shares issued	8,426	12,500		84,679	24,792	1,047,583	1,808		2,018,125
Shares Issued, Price Per Share		$ 0.78		$ 1.20	$ 0.48
Issuance of common stock for debt conversion, Shares											2,582,916
Proceeds from issuance of common stock, gross		$ 9,595			$ 11,875
Common Stock For Cashless Transaction For Warrant Exercise	25,000						25,000
Common stock issued for warrant exercise				101,615					2,018,125
Offering Price			$ 1			$ 1
Sale of common stock								5,775,000		2,800,000
Proceeds from sale of common stock								$ 5,775,000
Loss on conversion						$ 41,902				$ 232,462
Stock-based compensation expense											$ 260,000
Exercise Price			$ 1.25
Equity payable										100,862	$ 100,862
Principal
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Face amount						1,000,000				2,500,000
Accrued interest
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Face amount						$ 47,583				$ 82,916

9. Stock-based Plans and Stoc_3

9. Stock-based Plans and Stock-based Compensation (Details)	Mar. 11, 2019USD ($)employeeitem$ / sharesshares	Feb. 12, 2019USD ($)employeeitem$ / sharesshares	Jan. 07, 2019USD ($)employeeitem$ / sharesshares	Jan. 02, 2019USD ($)$ / sharesshares	Nov. 06, 2018shares	Jun. 02, 2018USD ($)employeeitem$ / sharesshares	May 07, 2018USD ($)employeeitem$ / sharesshares	Feb. 07, 2018USD ($)$ / sharesshares	Jan. 08, 2018USD ($)employeeitem$ / sharesshares	Jan. 02, 2018USD ($)employeeitem$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Nov. 19, 2019USD ($)employeeitem$ / sharesshares	Oct. 21, 2019USD ($)employeeitem$ / sharesshares	Aug. 21, 2019USD ($)employeeitem$ / sharesshares	May 17, 2019USD ($)employeeitem$ / sharesshares	Mar. 31, 2019USD ($)$ / sharesshares	Feb. 25, 2019USD ($)employeeitem$ / sharesshares	Feb. 18, 2019USD ($)employeeitem$ / sharesshares	Jan. 21, 2019USD ($)employeeitem$ / sharesshares	Oct. 19, 2018$ / sharesshares	Aug. 29, 2018USD ($)$ / sharesshares	Jun. 30, 2018shares	Apr. 16, 2018USD ($)employeeitem$ / sharesshares	Mar. 26, 2018USD ($)employeeitem$ / sharesshares	Feb. 23, 2018shares	Feb. 15, 2018USD ($)employeeitem$ / sharesshares	Jan. 29, 2018USD ($)employeeitem$ / sharesshares	Mar. 31, 2018shares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2017$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under stock plan | shares											5,781,884																		5,781,884
Shares available for future grants | shares											30,728,202																		30,728,202
Contractual terms (period)																													10 years
Options to purchase shares, in-the-money | shares											1,969,208																		1,969,208
Weighted average grant date fair value | $ / shares																													$ 0.71	$ 1.25
Number of employees, options granted | employee	1	1	1			1	1		1	2		12	1	4	3		1	1	1				1	1		1	1
Options granted | shares	50,000	150,000	10,000			10,000	10,000		50,000	10,000		237,500	150,000	140,000	1,775,000		50,000	15,000	15,000				50,000	300,000		100,000	20,000
Weighted average grant date fair value | $ / shares	$ 1	$ 1	$ 1.17			$ 1.12	$ 0.90		$ 1.20	$ 1.20		$ 0.88	$ 0.98	$ 0.95	$ 1.04		$ 1	$ 1.05	$ 1.17				$ 1.06	$ 1.10		$ 1.12	$ 1.03
Monthly installments in which options vest, after initial vesting Anniversary | item	48	48	48			48	48		48	48		36	36	36	48		48	48	48				48	48		48	48
Volatility rate	90.90%	90.79%	90.82%			95.44%	101.42%		104.06%	104.04%		78.70%	74.18%	80.17%	80.17%		90.88%	90.88%	90.75%				102.07%	101.94%		103.60%	103.49%
Call option value, price per share | $ / shares	$ 0.75	$ 0.75	$ 0.88			$ 0.87	$ 0.72		$ 0.97	$ 0.97		$ 0.60	$ 0.64	$ 0.65	$ 0.72		$ 0.75	$ 0.84	$ 0.88				$ 0.85	$ 0.88		$ 0.91	$ 0.83
Call option value | $	$ 37,688	$ 113,046	$ 8,821			$ 8,705	$ 7,231		$ 48,682	$ 9,729		$ 142,409	$ 96,165	$ 91,537	$ 1,283,178		$ 37,697	$ 12,537	$ 13,239				$ 42,693	$ 265,575		$ 90,904	$ 16,690
Shares issued | shares					8,426			12,500												84,679	24,792	1,047,583			1,808			2,018,125
Shares Issued, Price Per Share | $ / shares								$ 0.78												$ 1.20	$ 0.48
Proceeds from issuance of common stock, gross | $								$ 9,595													$ 11,875
Unearned stock based compensation expense | $											$ 1,568,273																		$ 1,568,273
Restricted stock units amortization | $																														$ 37,249
Board compensation | $																														$ 260,000
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Units issued | shares				222,224							195,000					72,224													489,448	0
Value of units | $				$ 260,000							$ 195,000					$ 65,001
Value of units, per share | $ / shares				$ 1.17							$ 1					$ 0.90													$ 1.04	$ 0	$ 0.73

9. Stock-based Plans and Stoc_4

9. Stock-based Plans and Stock-based Compensation: Stock Option Activitiy (Details) - Employee Stock Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Outstanding at Beginning of Period	4,987,426	6,818,948
Granted	2,592,500	855,000
Exercised	0	(37,292)
Forfeit/canceled	(923,389)	(1,566,589)
Expired	(874,653)	(1,082,641)
Outstanding at End of Period	5,781,884	4,987,426	6,818,948
Expected to vest at End of Period	5,781,884
Exercisable at End of Period	3,339,437
Unrecognized expense at End of Period	$ 1,568,273
Weighted Average Exercise Price Per Share
Outstanding at Beginning of Period	$ 1.16	$ 1.06
Granted	1.01	1.25
Exercised	.00	0.57
Forfeit/canceled	1	0.74
Expired	0.93	1.18
Outstanding at End of Period	1.15	$ 1.16	$ 1.06
Vested	1.15
Exercisable at end of period	$ 1.29
Weighted Average Remaining Contractual Life (Years)
Outstanding, Weighted Average Remaining Contractual Term (Years)	7 years 1 month 27 days	7 years 1 month 13 days	8 years 1 month 13 days
Expected, Weighted Average Remaining Contractual Term (Years)	7 years 1 month 27 days
Exercisable, Weighted Average Remaining Contractual Term (Years)	5 years 9 months 3 days
Aggregate Intrinsic value
Aggregate Intrinsic Value, Outstanding	$ 527,868	$ 1,215,067	$ 209,690
Aggregate Intrinsic Value, Exercised	0
Expected to vest at End of Period	527,868
Exercisable at End of Period	$ 343,255

9. Stock-based Plans and Stoc_5

9. Stock-based Plans and Stock-based Compensation: Stock Based Compensation Expense - Stock Option (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense		$ 260,000
Employee Stock Option [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 899,892	667,912
Employee Stock Option [Member] | General And Administrative Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	670,188	311,303
Employee Stock Option [Member] | Cost Of Sales [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	74,229	225,275
Employee Stock Option [Member] | Research And Development Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 155,475	$ 131,334

9. Stock-based Plans and Stoc_6

9. Stock-based Plans and Stock-based Compensation: Valuation Assumptions (Details)	Mar. 11, 2019	Feb. 12, 2019	Jan. 07, 2019	Jun. 02, 2018	May 07, 2018	Jan. 08, 2018	Jan. 02, 2018	Nov. 19, 2019	Oct. 21, 2019	Aug. 21, 2019	May 17, 2019	Feb. 25, 2019	Feb. 18, 2019	Jan. 21, 2019	Apr. 16, 2018	Mar. 26, 2018	Feb. 15, 2018	Jan. 29, 2018	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (years)																			6 years	6 years 22 days
Expected dividend yield																			0.00%	0.00%
Expected volatility	90.90%	90.79%	90.82%	95.44%	101.42%	104.06%	104.04%	78.70%	74.18%	80.17%	80.17%	90.88%	90.88%	90.75%	102.07%	101.94%	103.60%	103.49%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate																			1.49%	2.24%
Expected volatility																			74.18%	90.88%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate																			2.65%	3.10%
Expected volatility																			90.90%	104.06%

9. Stock-based Plans and Stoc_7

9. Stock-based Plans and Stock-based Compensation: Restricted Stock Unit Activity (Details) - Restricted Stock Units R S U [Member] - USD ($)	Jan. 02, 2019	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period				662,800	662,800
Awarded, Shares	222,224	195,000	72,224	489,448	0
Released, Shares				0	0
Forfeited, Shares				0	0
Outstanding at End of Period		1,152,248		1,152,248	662,800	662,800
Vested at end		1,152,248		1,152,248
Unvested at end		0		0
Unrecognized expense at end		$ 0		$ 0
Outstanding at beginning of period, Weighted Average Exercise Price				$ 0.72	$ 0.72
Awarded, Weighted Average Grant Date Fair Value	$ 1.17	$ 1	$ 0.90	1.04	0	$ 0.73
Exercised, Weighted Average Exercise Price				.00	0
Forfeited, Weighted Average Exercise Price				.00	0
Outstanding at end of period, Weighted Average Exercise Price		0.86		0.86	$ 0.72	$ 0.72
Expected to vest at end of period, Weighted Average Exercise Price		$ 0.72		$ 0.72
Outstanding, Weighted Average Remaining Contractual Term (Years)				8 months 12 days
Outstanding, aggregate intrinsic value		$ 1,120,404		$ 1,120,404	$ 785,418	$ 795,360
Released, aggregate intrinsic value				325,044
Vested, aggregate intrinsic value				$ 1,152,248

9. Stock-based Plans and Stoc_8

9. Stock-based Plans and Stock-based Compensation: Stock Based Compensation Expense - Restricted Stock (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 260,000
Restricted Stock Units R S U [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 263,378	297,249
Restricted Stock Units R S U [Member] | General And Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 263,378	$ 297,249

10. Warrants to Purchase Comm_3

10. Warrants to Purchase Common Stock (Details) - USD ($)	2 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			$ 260,000
Issuance of common stock for cashless warrant conversion, Amount
Investor Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 0	$ 0
Warrant Issuance [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants to purchase of common stock	2,018,125		84,679
Warrants outstanding	5,134,349
Warrants outstanding, per share	$ 1
Adjustment to APIC	$ 2,018,125
Common stock price			$ 1.20
Additional capital			$ 101,615
Issuance of common stock for cashless warrant conversion, Amount			$ 50,000
Issuance of common stock for cashless warrant conversion, Shares			10,234

10. Warrants to Purchase Comm_4

10. Warrants to Purchase Common Stock : Summary Of Non-Employee Warrant Activity (Details) - $ / shares	Mar. 11, 2019	Feb. 12, 2019	Jan. 07, 2019	Jun. 02, 2018	May 07, 2018	Jan. 08, 2018	Jan. 02, 2018	Nov. 19, 2019	Oct. 21, 2019	Aug. 21, 2019	May 17, 2019	Feb. 25, 2019	Feb. 18, 2019	Jan. 21, 2019	Apr. 16, 2018	Mar. 26, 2018	Feb. 15, 2018	Jan. 29, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted	50,000	150,000	10,000	10,000	10,000	50,000	10,000	237,500	150,000	140,000	1,775,000	50,000	15,000	15,000	50,000	300,000	100,000	20,000
Investor Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period			2,112,060			5,134,349								2,112,060				5,134,349	2,112,060	5,134,349
Granted																			2,691,459	0
Exercised																			0	(2,127,804)
Canceled/forfeited/expired																			(1,445,060)	(894,485)
Outstanding at End of Period																			3,358,459	2,112,060	5,134,349
Outstanding at beginning of period, Weighted Average Exercise Price			$ 1.19			$ 1.19								$ 1.19				$ 1.19	$ 1.19	$ 1.19
Awarded, Weighted Average Grant Date Fair Value																			0	0
Exercised, Weighted Average Exercise Price																			0	0
Cancelled/forfeited/expired, Weighted Average Exercise Price																			0	0
Outstanding at end of period, Weighted Average Exercise Price																			$ 1.23	$ 1.19	$ 1.19
Outstanding, Weighted Average Remaining Contractual Term (Years)																			1 year 3 months 8 days	1 year 2 months 1 day	2 years 2 months 1 day

11. Income Taxes (Details)

11. Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Operating Loss Carryforwards [Line Items]
Change in valuation allowance		$ 2,326,000	$ 2,088,000
Targeted deferred tax asset amount, after valuation allowance recorded		0
Change in ownership limit, operating loss		207,000
Pre change net operating loss carryforward		6,000,000
Liability for uncertain tax positions		0
Accrued interest and penalties		0
Effect of tax rate changes on deferred tax assets and liabilities		0	$ 7,657,000
Tax Cuts and Jobs Act of 2017, change in tax rate, deferred tax assets, valuation allowance		7,657,000
State And Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards		$ 51,000,000
State And Local Jurisdiction [Member] | Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Tax years subject to examination		2006
Domestic Country [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards		$ 51,000,000
Domestic Country [Member] | Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Tax years subject to examination		2006
Scenario Plan [Member]
Operating Loss Carryforwards [Line Items]
U. S. corporate income tax rate	21.00%

11. Income Taxes_ Provisions fo

11. Income Taxes: Provisions for income taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Federal - current	$ 0	$ 0
State - current	0	0
Foreign- current	0	0
Total	$ 0	$ 0

11. Income Taxes_ Net deferred

11. Income Taxes: Net deferred tax assets and liabilities (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets (liabilities):
Net operating loss carryforwards	$ 14,136,000	$ 11,621,000
Stock based compensation	3,877,000	3,551,000
Accrued compensation	34,000	16,000
Depreciation and amortization	4,241,000	4,759,000
Other	5,000	20,000
Total deferred tax assets	22,293,000	19,967,000
Valuation allowance for net deferred tax assets	(22,293,000)	(19,967,000)
Total	$ 0	$ 0

11. Income Taxes_ Reconciliatio

11. Income Taxes: Reconciliation of federal statutory income tax rate to our effective income tax rate (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Computed expected tax expense	$ (1,853,000)	$ (1,515,000)
State taxes, net of federal benefit	(581,000)	(630,000)
Expiration of NOL carryforwards	44,000	44,000
Other	64,000	13,000
Change in valuation allowance	2,326,000	2,088,000
Total	$ 0	$ 0

12. Fair Value Measurements o_3

12. Fair Value Measurements of Financial Instruments (Details) - Fair Value Measurements Recurring [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Fair Value Inputs Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	$ 0	$ 0
Intangibles, net	0	0
Fair Value Inputs Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	0	0
Intangibles, net	0	0
Fair Value Inputs Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	496,532	537,550
Intangibles, net	1,762,211	1,781,448
Goodwill [Member] | Change During Period Fair Value Disclosure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) from fair value measurement	0	0
Intangible Assets [Member] | Change During Period Fair Value Disclosure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) from fair value measurement	$ 0	$ 0

13. Commitments and Contingen_2

13. Commitments and Contingencies (Details)	12 Months Ended
	Dec. 31, 2019USD ($)ft²	Dec. 31, 2018USD ($)
Commitments And Contigencies [Line Items]
Operating lease asset	$ 260,645	$ 0
Mgage
Commitments And Contigencies [Line Items]
Litigation settlement	$ 300,000
CA-NS
Commitments And Contigencies [Line Items]
Lease area of office | ft²	3,248
Monthly rental expense	$ 2,979
Operating lease asset	65,776
Operating lease liability	75,741
A [Z]
Commitments And Contigencies [Line Items]
Common area maintenance charges	$ 20,140
Lease area of office | ft²	10,395
Operating lease asset	$ 194,869
Operating lease liability	$ 228,062

14. Employee Benefit Plan (Deta

14. Employee Benefit Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Retirement Benefits [Abstract]
Contributions to the Plan	$ 0	$ 0

15. Related Party Transactions

15. Related Party Transactions (Details) - USD ($)	1 Months Ended	12 Months Ended
	Feb. 28, 2018	Dec. 31, 2019	Feb. 28, 2022
Related Party Transaction [Line Items]
Debt, principal amount		$ 1,000,000	$ 200,000
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt, principal amount	$ 1,080,000
Stated rate	15.00%
Prepayment penalty, interest rate	2.00%
Repayment of related party debt		1,000,000
Related Party Note		80,000
Accrued interest		21,333
Unsecured Promissory Notes [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Debt, principal amount	$ 750,000
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt, principal amount		$ 3,500,000
Stated rate		15.00%
Prepayment penalty, interest rate		2.00%
Related Party Note		$ 1,000,000
Accrued interest		13,958
Loss on conversion of debt		$ 232,462
Debt Conversion, Converted Instrument, Shares Issued		2,582,916
Unsecured Promissory Notes [Member] | Principal
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount		$ 2,500,000
Unsecured Promissory Notes [Member] | Accrued interest
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount		$ 82,916

16. Subsequent Events (Details

16. Subsequent Events (Details Narrative) - USD ($)	Mar. 02, 2020	Feb. 26, 2020	Feb. 28, 2018	Feb. 28, 2022	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2018
Debt, principal amount				$ 200,000	$ 1,000,000
Warrant Issuance [Member]
Warrants to purchase of common stock						84,679	2,018,125
Warrants outstanding, per share							$ 1
Unsecured Promissory Notes [Member]
Debt, principal amount			$ 1,080,000
Stated rate			15.00%
Prepayment penalty, interest rate			2.00%
Subsequent Event [Member] | Warrant Issuance [Member]
Warrants to purchase of common stock	234,500
Warrants outstanding, per share	$ 1
Number of warrants exercised	234,500
Proceeds from warrants exercised	$ 234,500
Subsequent Event [Member] | Unsecured Promissory Notes [Member]
Debt, principal amount		$ 200,000
Stated rate		15.00%
Prepayment penalty, interest rate		2.00%